journal,year,volume,issue,DOI,SI,event,date
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010001,Normal Issue,"
Received",2016-01-21
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010001,Normal Issue, Accepted,2016-01-21
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010001,Normal Issue, Published,2016-01-21
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010002,Normal Issue,"
Received",2015-11-17
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010002,Normal Issue, Revised,2015-12-31
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010002,Normal Issue, Accepted,2016-01-18
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010002,Normal Issue, Published,2016-01-22
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010003,Normal Issue,"
Received",2015-12-07
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010003,Normal Issue, Revised,2016-01-15
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010003,Normal Issue, Accepted,2016-01-19
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010003,Normal Issue, Published,2016-01-21
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010004,Normal Issue,"
Received",2015-12-04
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010004,Normal Issue, Revised,2016-01-24
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010004,Normal Issue, Accepted,2016-02-14
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010004,Normal Issue, Published,2016-02-22
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010005,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)","
Received",2016-01-19
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010005,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Revised,2016-02-19
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010005,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Accepted,2016-02-25
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010005,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Published,2016-02-29
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010006,Normal Issue,"
Received",2015-11-04
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010006,Normal Issue, Revised,2016-01-11
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010006,Normal Issue, Accepted,2016-01-14
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010006,Normal Issue, Published,2016-03-11
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010007,Normal Issue,"
Received",2016-01-21
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010007,Normal Issue, Revised,2016-03-04
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010007,Normal Issue, Accepted,2016-03-11
Vaccines,2016,4,1,https://doi.org/10.3390/vaccines4010007,Normal Issue, Published,2016-03-17
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020008,Normal Issue,"
Received",2016-02-19
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020008,Normal Issue, Revised,2016-03-15
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020008,Normal Issue, Accepted,2016-03-18
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020008,Normal Issue, Published,2016-03-28
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020009,"
(This article belongs to the Special Issue Vaccine Delivery)","
Received",2016-03-24
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020009,"
(This article belongs to the Special Issue Vaccine Delivery)", Accepted,2016-03-25
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020009,"
(This article belongs to the Special Issue Vaccine Delivery)", Published,2016-03-28
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020010,Normal Issue,"
Received",2016-01-28
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020010,Normal Issue, Revised,2016-04-07
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020010,Normal Issue, Accepted,2016-04-08
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020010,Normal Issue, Published,2016-04-15
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020011,Normal Issue,"
Received",2016-03-02
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020011,Normal Issue, Revised,2016-04-12
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020011,Normal Issue, Accepted,2016-04-13
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020011,Normal Issue, Published,2016-04-19
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020012,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)","
Received",2016-02-24
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020012,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Revised,2016-03-28
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020012,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Accepted,2016-04-01
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020012,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Published,2016-04-19
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020013,Normal Issue,"
Received",2016-02-08
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020013,Normal Issue, Revised,2016-04-11
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020013,Normal Issue, Accepted,2016-04-20
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020013,Normal Issue, Published,2016-04-26
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020014,Normal Issue,"
Received",2016-02-16
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020014,Normal Issue, Revised,2016-04-20
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020014,Normal Issue, Accepted,2016-04-25
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020014,Normal Issue, Published,2016-05-04
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020015,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)","
Received",2016-02-25
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020015,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Revised,2016-04-22
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020015,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Accepted,2016-04-26
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020015,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Published,2016-05-05
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020016,Normal Issue,"
Received",2015-12-24
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020016,Normal Issue, Revised,2016-03-24
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020016,Normal Issue, Accepted,2016-04-25
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020016,Normal Issue, Published,2016-05-10
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020017,Normal Issue,"
Received",2016-03-14
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020017,Normal Issue, Revised,2016-04-12
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020017,Normal Issue, Accepted,2016-04-25
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020017,Normal Issue, Published,2016-05-13
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020018,Normal Issue,"
Received",2016-02-08
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020018,Normal Issue, Revised,2016-03-31
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020018,Normal Issue, Accepted,2016-04-08
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020018,Normal Issue, Published,2016-06-01
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020019,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)","
Received",2016-04-10
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020019,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Revised,2016-05-10
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020019,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Accepted,2016-05-12
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020019,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Published,2016-05-20
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020020,Normal Issue,"
Received",2016-02-04
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020020,Normal Issue, Revised,2016-04-29
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020020,Normal Issue, Accepted,2016-05-20
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020020,Normal Issue, Published,2016-05-27
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020021,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-04-18
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020021,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-05-20
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020021,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-05-25
Vaccines,2016,4,2,https://doi.org/10.3390/vaccines4020021,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-06-01
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030022,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-04-11
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030022,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-05-31
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030022,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-06-21
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030022,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-06-24
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030023,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)","
Received",2016-05-17
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030023,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Revised,2016-06-20
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030023,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Accepted,2016-06-21
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030023,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Published,2016-06-29
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030024,Normal Issue,"
Received",2016-06-02
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030024,Normal Issue, Revised,2016-07-11
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030024,Normal Issue, Accepted,2016-07-13
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030024,Normal Issue, Published,2016-07-19
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030025,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)","
Received",2016-04-19
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030025,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Revised,2016-07-13
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030025,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Accepted,2016-07-21
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030025,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Published,2016-07-26
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030026,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)","
Received",2016-05-01
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030026,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Revised,2016-07-11
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030026,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Accepted,2016-07-12
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030026,"
(This article belongs to the Special Issue Cytokine JAK-STAT Signaling in Immunity)", Published,2016-07-26
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030027,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2016-06-07
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030027,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2016-07-19
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030027,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2016-07-19
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030027,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2016-08-02
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030028,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-06-14
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030028,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-07-27
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030028,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-08-01
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030028,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-08-06
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030029,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-07-07
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030029,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-08-25
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030029,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-08-27
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030029,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-09-02
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030030,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2016-06-15
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030030,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2016-08-18
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030030,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2016-08-26
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030030,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2016-09-05
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030031,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-07-14
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030031,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-09-02
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030031,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-09-07
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030031,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-09-09
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030032,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-07-13
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030032,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-08-16
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030032,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-09-05
Vaccines,2016,4,3,https://doi.org/10.3390/vaccines4030032,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-09-12
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040033,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2016-07-18
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040033,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2016-09-27
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040033,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2016-10-13
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040034,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-08-23
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040034,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-09-25
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040034,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-09-29
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040034,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-10-12
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040035,"
 (This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-08-16
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040035,"
 (This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-09-12
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040035,"
 (This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-09-28
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040035,"
 (This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-10-20
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040036,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-08-15
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040036,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-10-04
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040036,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-10-31
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040036,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-11-03
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040037,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-08-27
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040037,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-10-23
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040037,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-10-31
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040037,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-11-03
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040038,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-07-27
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040038,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-09-14
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040038,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-10-31
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040038,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-11-04
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040039,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-07-13
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040039,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-10-14
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040039,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-10-28
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040039,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-11-07
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040040,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-07-14
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040040,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-10-21
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040040,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-10-28
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040040,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-11-07
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040041,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-06-21
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040041,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-10-01
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040041,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-10-31
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040041,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-11-08
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040042,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-07-22
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040042,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-09-23
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040042,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-11-04
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040042,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-11-09
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040043,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-08-27
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040043,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-10-17
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040043,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-11-01
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040043,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-11-14
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040044,Normal Issue,"
Received",2016-08-31
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040044,Normal Issue, Revised,2016-10-28
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040044,Normal Issue, Accepted,2016-11-09
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040044,Normal Issue, Published,2016-11-17
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040045,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-10-18
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040045,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-11-22
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040045,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-11-22
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040045,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-12-02
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040046,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-08-27
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040046,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2016-11-01
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040046,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2016-11-25
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040046,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2016-12-06
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040047,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-08-01
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040047,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-11-26
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040047,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2016-11-30
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040047,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2016-12-06
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040048,Normal Issue,"
Received",2016-10-30
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040048,Normal Issue, Revised,2016-12-06
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040048,Normal Issue, Accepted,2016-12-08
Vaccines,2016,4,4,https://doi.org/10.3390/vaccines4040048,Normal Issue, Published,2016-12-13
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010001,Normal Issue,"
Received",2016-07-28
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010001,Normal Issue, Revised,2016-11-14
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010001,Normal Issue, Accepted,2016-11-23
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010001,Normal Issue, Published,2016-12-29
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010002,Normal Issue,"
Received",2017-01-10
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010002,Normal Issue, Revised,2017-01-10
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010002,Normal Issue, Accepted,2017-01-10
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010002,Normal Issue, Published,2017-01-10
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010003,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-07-16
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010003,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2016-12-23
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010003,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2017-01-06
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010003,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2017-01-19
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010004,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)","
Received",2016-07-14
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010004,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Revised,2016-11-14
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010004,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Accepted,2017-01-22
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010004,"
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)", Published,2017-01-27
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010005,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2016-07-18
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010005,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2016-11-03
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010005,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2017-01-17
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010005,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2017-02-04
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010006,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)","
Received",2016-09-30
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010006,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Revised,2017-01-23
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010006,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Accepted,2017-01-25
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010006,"
(This article belongs to the Special Issue Nanoparticles to Co-Deliver Immunopotentiators and Antigens)", Published,2017-02-14
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010007,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)","
Received",2016-11-18
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010007,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Revised,2017-01-26
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010007,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Accepted,2017-02-17
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010007,"
(This article belongs to the Special Issue Mechanisms of Tumor Escape from Host Immunity)", Published,2017-02-27
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010008,Normal Issue,"
Received",2016-11-30
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010008,Normal Issue, Revised,2017-02-17
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010008,Normal Issue, Accepted,2017-02-22
Vaccines,2017,5,1,https://doi.org/10.3390/vaccines5010008,Normal Issue, Published,2017-03-06
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020009,Normal Issue,"
Received",2017-03-15
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020009,Normal Issue, Revised,2017-04-06
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020009,Normal Issue, Accepted,2017-04-07
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020009,Normal Issue, Published,2017-04-12
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020010,Normal Issue,"
Received",2017-02-24
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020010,Normal Issue, Revised,2017-04-18
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020010,Normal Issue, Accepted,2017-04-21
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020010,Normal Issue, Published,2017-05-02
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020011,Normal Issue,"
Received",2017-03-28
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020011,Normal Issue, Revised,2017-05-03
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020011,Normal Issue, Accepted,2017-05-11
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020011,Normal Issue, Published,2017-05-17
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020012,Normal Issue,"
Received",2016-11-09
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020012,Normal Issue, Revised,2017-02-06
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020012,Normal Issue, Accepted,2017-05-15
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020012,Normal Issue, Published,2017-05-18
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020013,Normal Issue,"
Received",2017-03-24
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020013,Normal Issue, Revised,2017-05-07
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020013,Normal Issue, Accepted,2017-05-19
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020013,Normal Issue, Published,2017-05-24
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020014,Normal Issue,"
Received",2017-02-17
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020014,Normal Issue, Revised,2017-05-19
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020014,Normal Issue, Accepted,2017-05-23
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020014,Normal Issue, Published,2017-05-30
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020015,Normal Issue,"
Received",2017-03-20
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020015,Normal Issue, Revised,2017-05-24
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020015,Normal Issue, Accepted,2017-05-27
Vaccines,2017,5,2,https://doi.org/10.3390/vaccines5020015,Normal Issue, Published,2017-06-02
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030016,"
(This article belongs to the Special Issue Host Responses to Viral Infection)","
Received",2017-03-30
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030016,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Revised,2017-06-23
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030016,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Accepted,2017-06-28
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030016,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Published,2017-07-03
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030017,Normal Issue,"
Received",2017-05-30
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030017,Normal Issue, Revised,2017-07-06
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030017,Normal Issue, Accepted,2017-07-07
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030017,Normal Issue, Published,2017-07-17
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030018,Normal Issue,"
Received",2017-06-08
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030018,Normal Issue, Revised,2017-07-04
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030018,Normal Issue, Accepted,2017-07-06
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030018,Normal Issue, Published,2017-07-18
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030019,Normal Issue,"
Received",2017-04-12
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030019,Normal Issue, Revised,2017-06-19
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030019,Normal Issue, Accepted,2017-07-21
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030019,Normal Issue, Published,2017-07-27
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030020,Normal Issue,"
Received",2017-05-09
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030020,Normal Issue, Revised,2017-07-24
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030020,Normal Issue, Accepted,2017-07-26
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030020,Normal Issue, Published,2017-08-01
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030021,Normal Issue,"
Received",2017-05-03
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030021,Normal Issue, Revised,2017-07-29
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030021,Normal Issue, Accepted,2017-08-02
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030021,Normal Issue, Published,2017-08-09
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030022,Normal Issue,"
Received",2017-06-02
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030022,Normal Issue, Revised,2017-07-19
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030022,Normal Issue, Accepted,2017-07-31
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030022,Normal Issue, Published,2017-08-12
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030023,"
(This article belongs to the Special Issue Host Responses to Viral Infection)","
Received",2017-07-08
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030023,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Revised,2017-08-09
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030023,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Accepted,2017-08-17
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030023,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Published,2017-08-22
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030024,"
(This article belongs to the Special Issue Host Responses to Viral Infection)","
Received",2017-07-28
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030024,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Revised,2017-08-25
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030024,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Accepted,2017-08-30
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030024,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Published,2017-09-01
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030025,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2017-08-02
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030025,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2017-08-24
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030025,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2017-08-29
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030025,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2017-09-02
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030026,Normal Issue,"
Received",2017-08-02
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030026,Normal Issue, Revised,2017-09-01
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030026,Normal Issue, Accepted,2017-09-14
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030026,Normal Issue, Published,2017-09-19
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030027,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)","
Received",2017-08-09
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030027,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Revised,2017-09-08
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030027,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Accepted,2017-09-14
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030027,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Published,2017-09-19
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030028,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)","
Received",2017-08-11
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030028,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Revised,2017-09-06
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030028,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Accepted,2017-09-14
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030028,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Published,2017-09-19
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030029,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)","
Received",2017-08-30
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030029,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Revised,2017-09-16
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030029,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Accepted,2017-09-18
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030029,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Published,2017-09-19
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030030,"
(This article belongs to the Special Issue Host Responses to Viral Infection)","
Received",2017-08-04
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030030,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Revised,2017-09-12
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030030,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Accepted,2017-09-12
Vaccines,2017,5,3,https://doi.org/10.3390/vaccines5030030,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Published,2017-09-20
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040031,"
(This article belongs to the Special Issue Microbial Antigen Delivery)","
Received",2017-08-14
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040031,"
(This article belongs to the Special Issue Microbial Antigen Delivery)", Revised,2017-09-13
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040031,"
(This article belongs to the Special Issue Microbial Antigen Delivery)", Accepted,2017-09-22
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040031,"
(This article belongs to the Special Issue Microbial Antigen Delivery)", Published,2017-09-26
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040032,Normal Issue,"
Received",2017-07-12
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040032,Normal Issue, Revised,2017-08-25
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040032,Normal Issue, Accepted,2017-09-20
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040032,Normal Issue, Published,2017-09-27
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040033,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2017-09-02
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040033,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2017-09-19
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040033,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2017-09-26
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040033,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2017-09-28
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040034,"
(This article belongs to the Special Issue TLR signaling in Immune Response)","
Received",2017-09-05
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040034,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Revised,2017-09-29
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040034,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Accepted,2017-10-01
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040034,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Published,2017-10-04
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040035,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)","
Received",2017-09-01
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040035,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Revised,2017-10-01
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040035,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Accepted,2017-10-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040035,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Published,2017-10-07
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040036,Normal Issue,"
Received",2017-08-25
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040036,Normal Issue, Revised,2017-10-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040036,Normal Issue, Accepted,2017-10-05
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040036,Normal Issue, Published,2017-10-10
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040037,"
(This article belongs to the Special Issue Host Responses to Viral Infection)","
Received",2017-09-26
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040037,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Revised,2017-10-12
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040037,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Accepted,2017-10-17
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040037,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Published,2017-10-20
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040038,Normal Issue,"
Received",2017-09-16
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040038,Normal Issue, Revised,2017-10-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040038,Normal Issue, Accepted,2017-10-20
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040038,Normal Issue, Published,2017-10-26
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040039,Normal Issue,"
Received",2017-10-13
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040039,Normal Issue, Revised,2017-10-26
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040039,Normal Issue, Accepted,2017-10-27
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040039,Normal Issue, Published,2017-10-31
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040040,"
(This article belongs to the Special Issue Host Responses to Viral Infection)","
Received",2017-09-05
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040040,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Revised,2017-10-30
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040040,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Accepted,2017-10-31
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040040,"
(This article belongs to the Special Issue Host Responses to Viral Infection)", Published,2017-11-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040041,Normal Issue,"
Received",2017-10-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040041,Normal Issue, Revised,2017-10-31
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040041,Normal Issue, Accepted,2017-11-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040041,Normal Issue, Published,2017-11-04
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040042,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)","
Received",2017-09-06
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040042,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Revised,2017-10-19
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040042,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Accepted,2017-10-31
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040042,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Published,2017-11-08
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040043,Normal Issue,"
Received",2017-10-08
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040043,Normal Issue, Revised,2017-11-02
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040043,Normal Issue, Accepted,2017-11-06
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040043,Normal Issue, Published,2017-11-10
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040045,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)","
Received",2017-10-13
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040045,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Revised,2017-11-14
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040045,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Accepted,2017-11-29
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040045,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Published,2017-12-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040046,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)","
Received",2017-10-24
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040046,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Revised,2017-11-15
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040046,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Accepted,2017-11-29
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040046,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Published,2017-12-04
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040047,Normal Issue,"
Received",2017-10-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040047,Normal Issue, Revised,2017-11-29
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040047,Normal Issue, Accepted,2017-12-01
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040047,Normal Issue, Published,2017-12-06
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040048,Normal Issue,"
Received",2017-10-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040048,Normal Issue, Revised,2017-11-20
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040048,Normal Issue, Accepted,2017-12-03
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040048,Normal Issue, Published,2017-12-06
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040049,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2017-11-23
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040049,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2017-12-05
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040049,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2017-12-06
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040049,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2017-12-09
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040050,Normal Issue,"
Received",2017-11-23
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040050,Normal Issue, Revised,2017-12-05
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040050,Normal Issue, Accepted,2017-12-06
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040050,Normal Issue, Published,2017-12-11
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040051,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)","
Received",2017-11-27
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040051,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Revised,2017-12-11
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040051,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Accepted,2017-12-12
Vaccines,2017,5,4,https://doi.org/10.3390/vaccines5040051,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Published,2017-12-13
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010001,Normal Issue,"
Received",2017-10-31
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010001,Normal Issue, Revised,2017-11-16
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010001,Normal Issue, Accepted,2017-11-21
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010001,Normal Issue, Published,2017-12-25
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010002,"
(This article belongs to the Special Issue TLR signaling in Immune Response)","
Received",2017-10-30
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010002,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Revised,2017-12-02
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010002,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Accepted,2017-12-21
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010002,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Published,2017-12-25
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010003,Normal Issue,"
Received",2017-11-13
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010003,Normal Issue, Revised,2018-01-01
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010003,Normal Issue, Accepted,2018-01-03
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010003,Normal Issue, Published,2018-01-05
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010004,Normal Issue,"
Received",2018-01-09
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010004,Normal Issue, Revised,2018-01-09
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010004,Normal Issue, Accepted,2018-01-09
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010004,Normal Issue, Published,2018-01-09
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010005,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2017-11-26
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010005,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2018-01-04
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010005,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2018-01-06
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010005,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2018-01-10
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010006,"
(This article belongs to the Special Issue TLR signaling in Immune Response)","
Received",2017-12-10
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010006,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Revised,2018-01-06
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010006,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Accepted,2018-01-11
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010006,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Published,2018-01-16
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010007,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)","
Received",2017-11-23
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010007,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Revised,2018-01-12
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010007,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Accepted,2018-01-14
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010007,"
(This article belongs to the Special Issue Vaccines against Emerging and Reemerging Viral Diseases of Humans and Animals)", Published,2018-01-18
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010008,Normal Issue,"
Received",2017-12-11
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010008,Normal Issue, Revised,2018-01-15
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010008,Normal Issue, Accepted,2018-01-26
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010008,Normal Issue, Published,2018-01-29
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010009,Normal Issue,"
Received",2017-12-05
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010009,Normal Issue, Revised,2018-01-22
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010009,Normal Issue, Accepted,2018-01-26
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010009,Normal Issue, Published,2018-01-30
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010010,Normal Issue,"
Received",2018-01-04
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010010,Normal Issue, Revised,2018-02-02
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010010,Normal Issue, Accepted,2018-02-10
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010010,Normal Issue, Published,2018-02-11
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010011,Normal Issue,"
Received",2017-12-23
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010011,Normal Issue, Revised,2018-01-26
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010011,Normal Issue, Accepted,2018-02-02
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010011,Normal Issue, Published,2018-02-14
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010012,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2018-01-30
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010012,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2018-02-21
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010012,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2018-02-23
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010012,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2018-02-25
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010013,"
(This article belongs to the Special Issue TLR signaling in Immune Response)","
Received",2018-01-16
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010013,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Revised,2018-02-19
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010013,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Accepted,2018-02-22
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010013,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Published,2018-02-28
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010014,Normal Issue,"
Received",2018-02-02
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010014,Normal Issue, Revised,2018-02-26
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010014,Normal Issue, Accepted,2018-03-05
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010014,Normal Issue, Published,2018-03-08
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010015,Normal Issue,"
Received",2018-01-07
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010015,Normal Issue, Revised,2018-02-15
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010015,Normal Issue, Accepted,2018-02-21
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010015,Normal Issue, Published,2018-03-12
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010016,Normal Issue,"
Received",2018-02-26
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010016,Normal Issue, Revised,2018-03-16
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010016,Normal Issue, Accepted,2018-03-18
Vaccines,2018,6,1,https://doi.org/10.3390/vaccines6010016,Normal Issue, Published,2018-03-19
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020017,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-03-02
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020017,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-03-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020017,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-03-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020017,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-03-26
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020018,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-02-28
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020018,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-03-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020018,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-03-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020018,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-03-26
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020019,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-02-28
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020019,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-03-26
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020019,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-03-27
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020019,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-03-30
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020020,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-02-28
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020020,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-03-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020020,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-03-27
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020020,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-04-01
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020021,"
(This article belongs to the Special Issue TLR signaling in Immune Response)","
Received",2018-02-01
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020021,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Revised,2018-03-25
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020021,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Accepted,2018-03-30
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020021,"
(This article belongs to the Special Issue TLR signaling in Immune Response)", Published,2018-04-05
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020022,Normal Issue,"
Received",2018-02-09
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020022,Normal Issue, Revised,2018-03-26
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020022,Normal Issue, Accepted,2018-03-26
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020022,Normal Issue, Published,2018-04-10
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020023,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-03-02
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020023,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-04-09
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020023,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-04-10
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020023,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-04-12
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020024,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
 Received",2018-04-04
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020024,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-04-20
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020024,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-04-25
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020024,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-04-27
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020025,Normal Issue,"
Received",2018-02-16
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020025,Normal Issue, Revised,2018-04-27
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020025,Normal Issue, Accepted,2018-04-28
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020025,Normal Issue, Published,2018-05-02
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020026,Normal Issue,"
Received",2018-05-14
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020026,Normal Issue, Revised,2018-05-14
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020026,Normal Issue, Accepted,2018-05-14
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020026,Normal Issue, Published,2018-05-15
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020027,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-04-09
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020027,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-05-08
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020027,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-05-10
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020027,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-05-17
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020028,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-04-28
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020028,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-05-14
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020028,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-05-16
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020028,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-05-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020029,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-04-19
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020029,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-05-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020029,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-05-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020029,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-05-24
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020030,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2018-04-30
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020030,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2018-05-18
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020030,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2018-05-22
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020030,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2018-05-24
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020031,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-03-17
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020031,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-05-11
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020031,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-05-21
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020031,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-05-25
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020032,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-03-23
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020032,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-05-23
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020032,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-05-23
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020032,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-05-26
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020033,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-05-29
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020033,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-05-29
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020033,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-05-31
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020034,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2018-05-11
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020034,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2018-06-05
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020034,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2018-06-06
Vaccines,2018,6,2,https://doi.org/10.3390/vaccines6020034,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2018-06-08
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030035,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)","
Received",2018-06-11
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030035,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Revised,2018-06-23
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030035,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Accepted,2018-06-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030035,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Published,2018-06-26
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030036,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-05-27
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030036,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-06-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030036,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-06-26
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030036,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-06-29
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030037,Normal Issue,"
Received",2018-05-11
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030037,Normal Issue, Revised,2018-06-21
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030037,Normal Issue, Accepted,2018-06-28
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030037,Normal Issue, Published,2018-07-02
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030038,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)","
Received",2018-05-15
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030038,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Revised,2018-06-27
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030038,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Accepted,2018-06-28
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030038,"
(This article belongs to the Special Issue Prevention of Respiratory Viral Infection: Vaccine, Antiviral and Immune-Modulator)", Published,2018-07-02
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030039,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)","
Received",2018-05-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030039,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Revised,2018-06-29
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030039,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Accepted,2018-06-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030039,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Published,2018-07-03
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030040,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-05-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030040,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-06-26
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030040,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-07-05
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030040,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-07-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030041,"
(This article belongs to the Special Issue Microparticles-based Vaccines)","
Received",2018-05-31
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030041,"
(This article belongs to the Special Issue Microparticles-based Vaccines)", Revised,2018-06-29
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030041,"
(This article belongs to the Special Issue Microparticles-based Vaccines)", Accepted,2018-07-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030041,"
(This article belongs to the Special Issue Microparticles-based Vaccines)", Published,2018-07-10
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030042,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-05-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030042,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-07-12
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030042,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-07-16
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030042,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-07-18
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030043,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2018-07-05
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030043,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2018-07-16
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030043,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2018-07-20
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030043,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2018-07-21
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030044,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-05-16
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030044,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-07-16
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030044,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-07-18
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030044,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-07-23
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030045,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)","
Received",2018-07-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030045,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Revised,2018-07-19
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030045,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Accepted,2018-07-23
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030045,"
(This article belongs to the Collection Vaccines against Chronic and Persistent Bacterial Infections)", Published,2018-07-24
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030046,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-06-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030046,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-07-17
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030046,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-07-21
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030046,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-07-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030047,Normal Issue,"
Received",2018-04-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030047,Normal Issue, Revised,2018-07-14
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030047,Normal Issue, Accepted,2018-07-17
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030047,Normal Issue, Published,2018-07-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030048,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-06-22
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030048,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-07-21
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030048,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-07-23
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030048,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-07-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030049,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-07-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030049,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-07-23
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030049,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-07-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030049,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-07-28
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030050,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2018-06-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030050,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2018-07-26
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030050,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2018-07-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030050,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2018-07-31
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030051,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-07-16
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030051,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-08-01
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030051,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-08-03
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030051,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-08-07
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030052,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-06-08
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030052,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-07-23
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030052,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-08-07
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030052,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-08-09
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030053,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)","
Received",2018-06-29
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030053,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Revised,2018-08-03
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030053,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Accepted,2018-08-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030053,"
(This article belongs to the Special Issue The Role of Hemagglutinin in Influenza Viruses Infection)", Published,2018-08-10
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030054,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-07-13
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030054,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-08-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030054,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-08-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030054,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-08-10
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030055,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-07-17
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030055,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-08-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030055,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-08-12
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030056,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-07-13
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030056,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-08-17
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030056,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-08-22
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030056,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-08-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030057,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-08-08
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030057,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-08-21
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030057,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-08-25
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030057,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-08-28
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030058,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-07-07
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030058,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-08-21
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030058,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-08-27
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030058,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-08-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030059,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-08-12
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030059,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2018-08-28
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030059,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2018-08-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030059,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2018-08-31
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030060,"
(This article belongs to the Special Issue Microparticles-based Vaccines)","
Received",2018-07-22
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030060,"
(This article belongs to the Special Issue Microparticles-based Vaccines)", Revised,2018-08-24
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030060,"
(This article belongs to the Special Issue Microparticles-based Vaccines)", Accepted,2018-08-27
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030060,"
(This article belongs to the Special Issue Microparticles-based Vaccines)", Published,2018-09-04
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030061,Normal Issue,"
Received",2018-07-12
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030061,Normal Issue, Revised,2018-08-26
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030061,Normal Issue, Accepted,2018-09-06
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030061,Normal Issue, Published,2018-09-08
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030062,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)","
Received",2018-08-20
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030062,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Revised,2018-09-08
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030062,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Accepted,2018-09-11
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030062,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Published,2018-09-13
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030063,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-07-17
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030063,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-08-30
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030063,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-09-12
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030063,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-09-14
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030064,Normal Issue,"
Received",2018-07-31
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030064,Normal Issue, Revised,2018-09-07
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030064,Normal Issue, Accepted,2018-09-11
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030064,Normal Issue, Published,2018-09-14
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030065,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-08-27
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030065,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-09-17
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030065,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-09-18
Vaccines,2018,6,3,https://doi.org/10.3390/vaccines6030065,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-09-19
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040066,Normal Issue,"
Received",2018-07-17
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040066,Normal Issue, Revised,2018-09-06
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040066,Normal Issue, Accepted,2018-09-14
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040066,Normal Issue, Published,2018-09-20
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040067,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-06-28
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040067,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-09-10
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040067,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-09-11
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040067,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-09-20
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040068,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2018-08-17
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040068,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2018-09-16
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040068,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2018-09-18
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040068,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2018-09-22
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040069,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-07-26
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040069,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-09-19
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040069,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-09-21
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040069,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-09-26
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040070,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)","
Received",2018-09-12
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040070,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Revised,2018-09-24
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040070,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Accepted,2018-09-26
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040070,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Published,2018-10-02
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040071,Normal Issue,"
Received",2018-08-08
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040071,Normal Issue, Revised,2018-09-06
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040071,Normal Issue, Accepted,2018-09-14
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040071,Normal Issue, Published,2018-10-04
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040072,Normal Issue,"
Received",2018-09-11
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040072,Normal Issue, Revised,2018-10-09
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040072,Normal Issue, Accepted,2018-10-11
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040072,Normal Issue, Published,2018-10-13
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040073,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2018-08-16
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040073,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2018-10-11
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040073,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2018-10-12
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040073,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2018-10-18
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040074,Normal Issue,"
Received",2018-08-30
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040074,Normal Issue, Revised,2018-09-21
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040074,Normal Issue, Accepted,2018-09-27
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040074,Normal Issue, Published,2018-11-01
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040075,Normal Issue,"
Received",2018-10-09
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040075,Normal Issue, Revised,2018-11-09
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040075,Normal Issue, Accepted,2018-11-13
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040075,Normal Issue, Published,2018-11-15
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040076,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)","
Received",2018-06-29
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040076,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Revised,2018-10-31
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040076,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Accepted,2018-11-16
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040076,"
(This article belongs to the Special Issue Host Defence Peptides: Modulation of Inflammation in Health and Disease)", Published,2018-11-20
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040077,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)","
Received",2018-10-28
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040077,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Revised,2018-11-16
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040077,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Accepted,2018-11-20
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040077,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Published,2018-11-21
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040078,Normal Issue,"
Received",2018-06-04
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040078,Normal Issue, Revised,2018-10-09
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040078,Normal Issue, Accepted,2018-11-16
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040078,Normal Issue, Published,2018-11-21
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040079,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2018-10-04
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040079,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2018-11-09
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040079,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2018-11-21
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040079,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2018-11-23
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040080,Normal Issue,"
Received",2018-11-07
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040080,Normal Issue, Accepted,2018-11-19
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040080,Normal Issue, Published,2018-11-27
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040081,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)","
Received",2018-10-17
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040081,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Revised,2018-11-01
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040081,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Accepted,2018-12-03
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040081,"
(This article belongs to the Special Issue Development of Vaccines against Zika Virus)", Published,2018-12-04
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040082,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-11-08
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040082,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2018-12-05
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040082,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2018-12-08
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040082,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2018-12-11
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040083,Normal Issue,"
Received",2018-09-01
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040083,Normal Issue, Revised,2018-10-08
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040083,Normal Issue, Accepted,2018-12-08
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040083,Normal Issue, Published,2018-12-13
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040084,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)","
Received",2018-11-06
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040084,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Revised,2018-12-05
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040084,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Accepted,2018-12-12
Vaccines,2018,6,4,https://doi.org/10.3390/vaccines6040084,"
(This article belongs to the Special Issue T Cell Memory to Vaccination)", Published,2018-12-14
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010001,Normal Issue,"
Received",2018-10-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010001,Normal Issue, Revised,2018-12-13
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010001,Normal Issue, Accepted,2018-12-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010001,Normal Issue, Published,2018-12-21
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010002,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2018-11-13
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010002,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2018-12-12
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010002,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2018-12-17
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010002,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2018-12-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010003,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2018-12-01
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010003,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2018-12-17
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010003,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2018-12-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010003,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2018-12-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010004,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-10-31
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010004,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2018-12-21
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010004,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2019-01-02
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010004,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2019-01-03
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010005,Normal Issue,"
Received",2018-06-28
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010005,Normal Issue, Revised,2018-12-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010005,Normal Issue, Accepted,2018-12-24
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010005,Normal Issue, Published,2019-01-05
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010006,Normal Issue,"
Received",2019-01-08
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010006,Normal Issue, Accepted,2019-01-08
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010006,Normal Issue, Published,2019-01-08
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010007,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2018-11-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010007,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2018-12-26
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010007,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-01-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010007,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-01-08
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010008,Normal Issue,"
Received",2018-11-16
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010008,Normal Issue, Revised,2019-01-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010008,Normal Issue, Accepted,2019-01-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010008,Normal Issue, Published,2019-01-16
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010009,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-11-30
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010009,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2019-01-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010009,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2019-01-16
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010009,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2019-01-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010010,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2018-10-31
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010010,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2019-01-10
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010010,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2019-01-16
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010010,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2019-01-21
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010011,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)","
Received",2018-12-18
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010011,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Revised,2019-01-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010011,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Accepted,2019-01-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010011,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Published,2019-01-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010012,Normal Issue,"
Received",2018-10-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010012,Normal Issue, Revised,2019-01-14
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010012,Normal Issue, Accepted,2019-01-23
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010012,Normal Issue, Published,2019-01-28
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010013,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-11-30
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010013,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2018-12-30
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010013,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2019-01-28
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010013,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2019-01-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010014,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-11-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010014,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2019-01-17
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010014,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2019-01-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010014,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2019-01-31
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010015,Normal Issue,"
Received",2019-01-24
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010015,Normal Issue, Accepted,2019-01-24
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010015,Normal Issue, Published,2019-01-31
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010016,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2018-11-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010016,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2019-01-28
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010016,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-01-30
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010016,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-02-01
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010017,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2018-11-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010017,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Revised,2019-01-30
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010017,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2019-01-30
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010017,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2019-02-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010018,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2018-12-31
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010018,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2019-01-31
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010018,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2019-02-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010018,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2019-02-11
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010019,Normal Issue,"
Received",2018-11-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010019,Normal Issue, Revised,2019-02-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010019,Normal Issue, Accepted,2019-02-07
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010019,Normal Issue, Published,2019-02-12
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010020,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)","
Received",2019-01-11
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010020,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)", Revised,2019-02-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010020,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)", Accepted,2019-02-07
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010020,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)", Published,2019-02-12
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010021,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)","
Received",2019-01-14
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010021,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)", Revised,2019-02-07
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010021,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)", Accepted,2019-02-11
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010021,"
(This article belongs to the Special Issue Virus-like particle & Nano-particle Vaccines: A Selection of papers from the conference of VLPNPV 2018)", Published,2019-02-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010022,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2018-12-17
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010022,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2019-02-06
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010022,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2019-02-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010022,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2019-02-20
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010023,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2019-01-16
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010023,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2019-02-13
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010023,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-02-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010023,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-02-23
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010024,Normal Issue,"
Received",2018-12-21
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010024,Normal Issue, Revised,2019-02-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010024,Normal Issue, Accepted,2019-02-21
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010024,Normal Issue, Published,2019-02-24
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010025,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)","
Received",2019-02-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010025,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Accepted,2019-02-25
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010025,"
(This article belongs to the Special Issue Vaccines for Pneumococcal Infections)", Published,2019-02-27
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010026,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2018-11-29
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010026,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2019-02-16
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010026,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-02-21
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010026,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-02-27
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010027,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
 Received",2018-10-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010027,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2019-02-24
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010027,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-02-27
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010027,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-03-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010028,Normal Issue,"
Received",2018-10-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010028,Normal Issue, Revised,2018-11-12
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010028,Normal Issue, Accepted,2018-12-17
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010028,Normal Issue, Published,2019-03-08
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010029,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-02-14
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010029,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-03-01
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010029,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-03-04
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010029,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-03-08
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010030,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2018-12-19
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010030,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2019-03-01
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010030,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2019-03-09
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010030,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2019-03-13
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010031,Normal Issue,"
Received",2019-02-18
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010031,Normal Issue, Accepted,2019-03-13
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010031,Normal Issue, Published,2019-03-14
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010032,Normal Issue,"
Received",2019-03-07
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010032,Normal Issue, Accepted,2019-03-13
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010032,Normal Issue, Published,2019-03-15
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010033,Normal Issue,"
Received",2019-01-22
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010033,Normal Issue, Revised,2019-02-27
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010033,Normal Issue, Accepted,2019-03-18
Vaccines,2019,7,1,https://doi.org/10.3390/vaccines7010033,Normal Issue, Published,2019-03-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020034,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-03-05
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020034,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-03-26
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020034,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-03-27
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020034,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-03-29
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020035,Normal Issue,"
Received",2019-02-01
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020035,Normal Issue, Revised,2019-03-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020035,Normal Issue, Accepted,2019-03-27
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020035,Normal Issue, Published,2019-04-02
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020036,Normal Issue,"
Received",2019-02-25
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020036,Normal Issue, Revised,2019-03-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020036,Normal Issue, Accepted,2019-04-04
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020036,Normal Issue, Published,2019-04-10
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020037,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-03-07
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020037,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-04-19
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020037,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-04-19
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020037,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-04-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020038,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-03-08
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020038,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-04-19
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020038,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-04-25
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020038,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-04-30
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020039,Normal Issue,"
Received",2019-03-30
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020039,Normal Issue, Revised,2019-04-20
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020039,Normal Issue, Accepted,2019-05-07
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020039,Normal Issue, Published,2019-05-12
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020040,Normal Issue,"
Received",2019-03-11
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020040,Normal Issue, Revised,2019-04-30
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020040,Normal Issue, Accepted,2019-05-08
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020040,Normal Issue, Published,2019-05-15
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-04-04
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2019-05-10
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2019-05-15
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2019-05-20
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020042,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-04-04
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020042,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-05-17
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020042,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-05-18
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020042,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-05-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020043,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-05-15
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020043,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-05-21
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020043,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-05-23
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020044,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-04-19
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020044,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-05-21
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020044,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-05-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020044,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-05-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020045,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)","
Received",2019-03-10
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020045,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Revised,2019-05-15
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020045,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Accepted,2019-05-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020045,"
(This article belongs to the Special Issue The Future of Influenza Virus Vaccines—Perspectives from the young investigators' point of view)", Published,2019-05-28
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020046,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-04-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020046,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-05-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020046,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-05-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020046,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-05-28
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020047,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-05-02
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020047,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-05-22
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020047,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-05-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020047,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-06-04
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020048,Normal Issue,"
Received",2019-05-03
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020048,Normal Issue, Revised,2019-05-25
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020048,Normal Issue, Accepted,2019-05-30
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020048,Normal Issue, Published,2019-06-07
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020049,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-05-13
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020049,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-06-06
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020049,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-06-08
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020049,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-06-12
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020050,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-04-17
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020050,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-06-07
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020050,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-06-11
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020050,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-06-13
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020051,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-05-06
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020051,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-06-06
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020051,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-06-10
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020051,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-06-14
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020052,Normal Issue,"
Received",2019-04-11
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020052,Normal Issue, Revised,2019-06-05
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020052,Normal Issue, Accepted,2019-06-07
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020052,Normal Issue, Published,2019-06-17
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020053,Normal Issue,"
Received",2019-05-20
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020053,Normal Issue, Revised,2019-06-15
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020053,Normal Issue, Accepted,2019-06-17
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020053,Normal Issue, Published,2019-06-18
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020054,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)","
Received",2019-06-03
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020054,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Revised,2019-06-17
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020054,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Accepted,2019-06-19
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020054,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Published,2019-06-20
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020055,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2019-05-28
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020055,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2019-06-15
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020055,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2019-06-20
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020055,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2019-06-24
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020056,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)","
Received",2019-05-19
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020056,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)", Revised,2019-06-21
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020056,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)", Accepted,2019-06-21
Vaccines,2019,7,2,https://doi.org/10.3390/vaccines7020056,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)", Published,2019-06-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030057,"
(This article belongs to the Section HIV Vaccines)","
Received",2019-05-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030057,"
(This article belongs to the Section HIV Vaccines)", Revised,2019-06-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030057,"
(This article belongs to the Section HIV Vaccines)", Accepted,2019-06-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030057,"
(This article belongs to the Section HIV Vaccines)", Published,2019-06-29
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030058,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-05-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030058,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-06-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030058,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-06-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030058,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-07-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030059,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2019-05-10
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030059,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2019-06-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030059,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-06-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030059,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-07-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030060,Normal Issue,"
Received",2019-05-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030060,Normal Issue, Revised,2019-06-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030060,Normal Issue, Accepted,2019-06-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030060,Normal Issue, Published,2019-07-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030061,"
(This article belongs to the Section Influenza Virus Vaccines)","
 Received",2019-05-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030061,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-06-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030061,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-07-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030061,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-07-08
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030062,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-05-31
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030062,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-07-02
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030062,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-07-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030062,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-07-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030063,Normal Issue,"
Received",2019-06-05
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030063,Normal Issue, Revised,2019-06-29
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030063,Normal Issue, Accepted,2019-07-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030063,Normal Issue, Published,2019-07-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030064,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-04-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030064,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-07-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030064,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-07-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030064,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030065,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)","
Received",2019-06-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030065,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Revised,2019-07-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030065,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Accepted,2019-07-08
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030065,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Published,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030066,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2019-06-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030066,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2019-07-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030066,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030066,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030067,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-06-07
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030067,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-07-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030067,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-07-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030067,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-07-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030068,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)","
Received",2019-05-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030068,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)", Revised,2019-07-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030068,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)", Accepted,2019-07-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030068,"
(This article belongs to the Special Issue Vaccines targeting African Swine Fever Virus)", Published,2019-07-18
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030069,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)","
Received",2019-05-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030069,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Revised,2019-07-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030069,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Accepted,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030069,"
(This article belongs to the Special Issue Vaccines for Respiratory Syncytial Virus)", Published,2019-07-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030070,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-05-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030070,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030070,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-07-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030070,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-07-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030071,Normal Issue,"
Received",2019-06-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030071,Normal Issue, Revised,2019-07-05
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030071,Normal Issue, Accepted,2019-07-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030071,Normal Issue, Published,2019-07-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030072,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)","
Received",2019-05-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030072,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Revised,2019-07-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030072,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Accepted,2019-07-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030072,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Published,2019-07-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030073,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)","
Received",2019-06-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030073,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Revised,2019-07-18
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030073,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Accepted,2019-07-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030073,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Published,2019-07-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030074,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-07-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030074,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-07-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030074,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-07-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030074,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-07-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030075,Normal Issue,"
Received",2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030075,Normal Issue, Accepted,2019-07-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030075,Normal Issue, Published,2019-07-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030076,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-07-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030076,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-07-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030076,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-07-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030076,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-07-29
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030077,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-07-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030077,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-07-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030077,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-07-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030077,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-07-31
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030078,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-05-10
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030078,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-07-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030078,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030078,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-08-02
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030079,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-07-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030079,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-07-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030079,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-07-29
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030079,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-08-02
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030080,Normal Issue,"
Received",2019-06-05
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030080,Normal Issue, Revised,2019-07-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030080,Normal Issue, Accepted,2019-07-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030080,Normal Issue, Published,2019-08-02
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030081,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-07-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030081,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-07-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030081,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-08-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030081,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-08-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030082,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-07-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030082,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-07-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030082,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-07-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030082,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030083,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-06-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030083,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030083,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2019-07-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030083,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030084,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-07-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030084,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-07-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030084,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-08-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030084,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030085,"
(This article belongs to the Section Immune Mechanisms)","
Received",2019-06-18
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030085,"
(This article belongs to the Section Immune Mechanisms)", Revised,2019-08-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030085,"
(This article belongs to the Section Immune Mechanisms)", Accepted,2019-08-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030085,"
(This article belongs to the Section Immune Mechanisms)", Published,2019-08-07
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030086,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-06-18
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030086,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-07-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030086,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-07-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030086,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-08-08
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030087,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-05-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030087,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-08-07
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030087,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-08-07
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030087,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-08-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030088,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2019-07-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030088,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2019-08-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030088,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030088,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2019-08-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030089,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2019-06-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030089,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030089,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2019-07-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030089,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2019-08-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030090,Normal Issue,"
Received",2019-06-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030090,Normal Issue, Revised,2019-07-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030090,Normal Issue, Accepted,2019-07-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030090,Normal Issue, Published,2019-08-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030091,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-05-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030091,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-08-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030091,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-08-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030091,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-08-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030092,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-03-29
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030092,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2019-06-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030092,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2019-08-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030092,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2019-08-20
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030093,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2019-06-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030093,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2019-08-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030093,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2019-08-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030093,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2019-08-20
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030094,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030094,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-08-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030094,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-08-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030094,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-08-20
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030095,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-08-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030095,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-08-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030095,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-08-20
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030095,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-08-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030096,"
(This article belongs to the Special Issue Immunization by Electroporation)","
Received",2019-07-08
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030096,"
(This article belongs to the Special Issue Immunization by Electroporation)", Revised,2019-08-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030096,"
(This article belongs to the Special Issue Immunization by Electroporation)", Accepted,2019-08-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030096,"
(This article belongs to the Special Issue Immunization by Electroporation)", Published,2019-08-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030097,"
(This article belongs to the Section Vaccines and Society)","
Received",2019-07-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030097,"
(This article belongs to the Section Vaccines and Society)", Revised,2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030097,"
(This article belongs to the Section Vaccines and Society)", Accepted,2019-08-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030097,"
(This article belongs to the Section Vaccines and Society)", Published,2019-08-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030098,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)","
Received",2019-07-31
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030098,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Revised,2019-08-20
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030098,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Accepted,2019-08-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030098,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Published,2019-08-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030099,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030099,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-08-08
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030099,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-08-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030099,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-08-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030100,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-04-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030100,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030100,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2019-08-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030100,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2019-08-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030101,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-06-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030101,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-08-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030101,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-08-20
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030101,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-08-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030102,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030102,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2019-08-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030102,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2019-08-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030102,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2019-08-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030103,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-08-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030103,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-08-27
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030103,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-08-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030103,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-08-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030104,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-07-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030104,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-08-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030104,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-08-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030104,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-09-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030105,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-07-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030105,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-08-29
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030105,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-08-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030105,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-09-02
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030106,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-07-05
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030106,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-08-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030106,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-08-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030106,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-09-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030107,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))","
Received",2019-08-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030107,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Revised,2019-08-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030107,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Accepted,2019-09-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030107,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Published,2019-09-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030108,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)","
Received",2019-07-01
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030108,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Revised,2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030108,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Accepted,2019-07-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030108,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Published,2019-09-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030109,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-07-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030109,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2019-08-21
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030109,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2019-09-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030109,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2019-09-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030110,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)","
Received",2019-07-18
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030110,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Revised,2019-08-25
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030110,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Accepted,2019-09-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030110,"
(This article belongs to the Special Issue New Horizons for Rabies Vaccines and Vaccination Strategies: Addressing 2030 Elimination Targets for Canine-mediated Rabies)", Published,2019-09-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030111,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-07-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030111,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-08-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030111,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-09-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030111,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-09-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030112,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2019-07-31
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030112,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2019-08-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030112,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2019-09-07
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030112,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2019-09-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030113,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)","
Received",2019-06-28
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030113,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Revised,2019-09-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030113,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Accepted,2019-09-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030113,"
(This article belongs to the Special Issue Pathogen-Host Interactions: Implications for Vaccine Design)", Published,2019-09-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030114,Normal Issue,"
Received",2019-07-24
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030114,Normal Issue, Revised,2019-09-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030114,Normal Issue, Accepted,2019-09-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030114,Normal Issue, Published,2019-09-15
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030115,"
(This article belongs to the Special Issue RNA Vaccines)","
Received",2019-07-30
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030115,"
(This article belongs to the Special Issue RNA Vaccines)", Revised,2019-09-09
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030115,"
(This article belongs to the Special Issue RNA Vaccines)", Accepted,2019-09-11
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030115,"
(This article belongs to the Special Issue RNA Vaccines)", Published,2019-09-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030116,Normal Issue,"
Received",2019-06-26
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030116,Normal Issue, Revised,2019-08-22
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030116,Normal Issue, Accepted,2019-09-04
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030116,Normal Issue, Published,2019-09-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030117,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2019-08-23
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030117,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2019-09-13
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030117,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2019-09-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030117,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2019-09-18
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030118,"
(This article belongs to the Section Epidemiology)","
Received",2019-08-06
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030118,"
(This article belongs to the Section Epidemiology)", Revised,2019-09-14
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030118,"
(This article belongs to the Section Epidemiology)", Accepted,2019-09-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030118,"
(This article belongs to the Section Epidemiology)", Published,2019-09-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030119,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-08-13
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030119,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-09-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030119,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-09-16
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030119,"

(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-09-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030120,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-08-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030120,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2019-09-12
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030120,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2019-09-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030120,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2019-09-19
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030121,Normal Issue,"
Received",2019-09-03
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030121,Normal Issue, Revised,2019-09-13
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030121,Normal Issue, Accepted,2019-09-17
Vaccines,2019,7,3,https://doi.org/10.3390/vaccines7030121,Normal Issue, Published,2019-09-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040122,"
(This article belongs to the Special Issue RNA Vaccines)","
Received",2019-08-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040122,"
(This article belongs to the Special Issue RNA Vaccines)", Revised,2019-09-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040122,"
(This article belongs to the Special Issue RNA Vaccines)", Accepted,2019-09-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040122,"
(This article belongs to the Special Issue RNA Vaccines)", Published,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040123,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2019-08-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040123,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2019-09-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040123,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2019-09-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040123,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040124,"
(This article belongs to the Section Immune Mechanisms)","
Received",2019-05-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040124,"
(This article belongs to the Section Immune Mechanisms)", Revised,2019-09-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040124,"
(This article belongs to the Section Immune Mechanisms)", Accepted,2019-09-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040124,"
(This article belongs to the Section Immune Mechanisms)", Published,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040125,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)","
Received",2019-08-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040125,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Revised,2019-09-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040125,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Accepted,2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040125,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Published,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040126,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-07-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040126,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2019-09-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040126,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2019-09-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040126,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2019-09-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040127,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)","
Received",2019-08-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040127,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Revised,2019-09-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040127,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Accepted,2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040127,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Published,2019-09-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040128,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-07-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040128,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-09-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040128,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040128,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-09-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040129,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-05-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040129,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-09-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040129,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-09-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040129,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-09-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040130,"
(This article belongs to the Section Vaccines and Society)","
Received",2019-07-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040130,"
(This article belongs to the Section Vaccines and Society)", Revised,2019-09-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040130,"
(This article belongs to the Section Vaccines and Society)", Accepted,2019-09-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040130,"
(This article belongs to the Section Vaccines and Society)", Published,2019-09-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040131,"
(This article belongs to the Special Issue RNA Vaccines)","
Received",2019-08-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040131,"
(This article belongs to the Special Issue RNA Vaccines)", Revised,2019-09-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040131,"
(This article belongs to the Special Issue RNA Vaccines)", Accepted,2019-09-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040131,"
(This article belongs to the Special Issue RNA Vaccines)", Published,2019-09-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040132,"
(This article belongs to the Special Issue RNA Vaccines)","
Received",2019-08-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040132,"
(This article belongs to the Special Issue RNA Vaccines)", Revised,2019-09-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040132,"
(This article belongs to the Special Issue RNA Vaccines)", Accepted,2019-09-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040132,"
(This article belongs to the Special Issue RNA Vaccines)", Published,2019-09-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040133,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2019-07-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040133,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040133,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2019-09-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040133,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2019-09-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040134,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-09-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040134,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040134,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-09-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040134,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-09-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040135,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-07-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040135,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-09-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040135,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-09-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040135,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-09-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040136,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-08-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040136,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-09-21
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040136,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-09-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040136,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-09-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040137,"
(This article belongs to the Section Epidemiology)","
Received",2019-08-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040137,"
(This article belongs to the Section Epidemiology)", Revised,2019-09-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040137,"
(This article belongs to the Section Epidemiology)", Accepted,2019-09-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040137,"
(This article belongs to the Section Epidemiology)", Published,2019-10-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040138,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)","
Received",2019-08-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040138,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Revised,2019-09-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040138,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Accepted,2019-09-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040138,"
(This article belongs to the Special Issue The Role of Host Cell-Mediated Immune Response in Hemorrhagic Fever Diseases)", Published,2019-10-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040139,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-08-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040139,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040139,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-10-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040139,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-10-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040140,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-09-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040140,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-09-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040140,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-10-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040141,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040141,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2019-09-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040141,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040142,Normal Issue,"
Received",2019-09-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040142,Normal Issue, Revised,2019-09-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040142,Normal Issue, Accepted,2019-09-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040142,Normal Issue, Published,2019-10-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040143,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-07-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040143,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-09-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040143,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-10-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040143,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-10-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040144,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-09-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040144,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040144,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040144,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2019-07-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040146,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-07-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040146,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-09-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040146,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-10-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040146,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-10-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040147,"
(This article belongs to the Section Epidemiology)","
Received",2019-07-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040147,"
(This article belongs to the Section Epidemiology)", Revised,2019-09-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040147,"
(This article belongs to the Section Epidemiology)", Accepted,2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040147,"
(This article belongs to the Section Epidemiology)", Published,2019-10-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040148,Normal Issue,"
Received",2019-08-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040148,Normal Issue, Revised,2019-10-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040148,Normal Issue, Accepted,2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040148,Normal Issue, Published,2019-10-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040149,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-09-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040149,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2019-10-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040149,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040149,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2019-10-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040150,Normal Issue,"
Received",2019-08-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040150,Normal Issue, Revised,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040150,Normal Issue, Accepted,2019-10-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040150,Normal Issue, Published,2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040151,Normal Issue,"
Received",2019-07-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040151,Normal Issue, Revised,2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040151,Normal Issue, Accepted,2019-10-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040151,Normal Issue, Published,2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040152,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-07-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040152,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-10-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040152,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-10-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040152,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-10-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040153,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040153,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2019-10-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040153,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2019-10-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040153,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2019-10-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040154,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)","
Received",2019-09-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040154,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Revised,2019-10-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040154,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Accepted,2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040154,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Published,2019-10-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040155,"
(This article belongs to the Section Vaccines and Society)","
Received",2019-09-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040155,"
(This article belongs to the Section Vaccines and Society)", Revised,2019-10-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040155,"
(This article belongs to the Section Vaccines and Society)", Accepted,2019-10-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040155,"
(This article belongs to the Section Vaccines and Society)", Published,2019-10-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040156,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)","
Received",2019-08-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040156,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Revised,2019-09-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040156,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Accepted,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040156,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Published,2019-10-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040157,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2019-09-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040157,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Revised,2019-10-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040157,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2019-10-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040157,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2019-10-21
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040158,"
(This article belongs to the Section Epidemiology)","
Received",2019-09-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040158,"
(This article belongs to the Section Epidemiology)", Revised,2019-10-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040158,"
(This article belongs to the Section Epidemiology)", Accepted,2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040158,"
(This article belongs to the Section Epidemiology)", Published,2019-10-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040159,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040159,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-10-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040159,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-10-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040159,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-10-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040160,Normal Issue,"
Received",2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040160,Normal Issue, Revised,2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040160,Normal Issue, Accepted,2019-10-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040160,Normal Issue, Published,2019-10-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040161,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)","
Received",2019-09-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040161,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Revised,2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040161,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Accepted,2019-10-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040161,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Published,2019-10-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040162,Normal Issue,"
Received",2019-08-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040162,Normal Issue, Revised,2019-10-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040162,Normal Issue, Accepted,2019-10-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040162,Normal Issue, Published,2019-10-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040163,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040163,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-10-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040163,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-10-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040163,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040164,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-10-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040164,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040164,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040164,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040165,Normal Issue,"
Received",2019-10-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040165,Normal Issue, Revised,2019-10-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040165,Normal Issue, Accepted,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040165,Normal Issue, Published,2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040166,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-09-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040166,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-10-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040166,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-10-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040166,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040167,Normal Issue,"
Received",2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040167,Normal Issue, Accepted,2019-10-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040167,Normal Issue, Published,2019-11-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040168,Normal Issue,"
Received",2019-08-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040168,Normal Issue, Revised,2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040168,Normal Issue, Accepted,2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040168,Normal Issue, Published,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040169,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-08-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040169,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040169,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-10-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040169,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040170,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-09-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040170,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040170,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040170,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040171,Normal Issue,"
Received",2019-09-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040171,Normal Issue, Revised,2019-10-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040171,Normal Issue, Accepted,2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040171,Normal Issue, Published,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040172,Normal Issue,"
Received",2019-10-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040172,Normal Issue, Revised,2019-10-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040172,Normal Issue, Accepted,2019-10-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040172,Normal Issue, Published,2019-11-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040173,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-08-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040173,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2019-10-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040173,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040173,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2019-11-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040174,Normal Issue,"
Received",2019-10-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040174,Normal Issue, Revised,2019-10-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040174,Normal Issue, Accepted,2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040174,Normal Issue, Published,2019-11-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040175,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2019-10-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040175,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Revised,2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040175,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040175,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2019-11-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040176,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-07-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040176,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-10-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040176,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040176,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-11-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040177,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-08-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040177,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040177,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2019-10-24
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040177,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2019-11-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040178,"
(This article belongs to the Section HIV Vaccines)","
Received",2019-10-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040178,"
(This article belongs to the Section HIV Vaccines)", Revised,2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040178,"
(This article belongs to the Section HIV Vaccines)", Accepted,2019-11-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040178,"
(This article belongs to the Section HIV Vaccines)", Published,2019-11-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040179,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)","
Received",2019-10-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040179,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Revised,2019-10-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040179,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Accepted,2019-11-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040179,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Published,2019-11-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040180,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-08-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040180,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-11-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040180,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-11-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040180,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-11-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040181,Normal Issue,"
Received",2019-10-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040181,Normal Issue, Revised,2019-11-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040181,Normal Issue, Accepted,2019-11-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040181,Normal Issue, Published,2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040182,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040182,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Revised,2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040182,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040182,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2019-11-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040183,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040183,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2019-11-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040183,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040183,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2019-11-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040184,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2019-10-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040184,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2019-11-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040184,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040184,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2019-11-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040185,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-10-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040185,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040185,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-11-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040185,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-11-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040186,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040186,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2019-11-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040186,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2019-11-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040186,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2019-11-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040187,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-10-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040187,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-11-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040187,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-11-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040187,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-11-17
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040188,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2019-09-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040188,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Revised,2019-11-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040188,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040188,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2019-11-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040189,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2019-10-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040189,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2019-11-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040189,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2019-11-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040189,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040190,Normal Issue,"
Received",2019-10-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040190,Normal Issue, Revised,2019-11-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040190,Normal Issue, Accepted,2019-11-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040190,Normal Issue, Published,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040191,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-09-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040191,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-11-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040191,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-11-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040191,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-11-21
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040192,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-09-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040192,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-11-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040192,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040192,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-11-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040193,Normal Issue,"
Received",2019-10-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040193,Normal Issue, Revised,2019-11-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040193,Normal Issue, Accepted,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040193,Normal Issue, Published,2019-11-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040194,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-11-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040194,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040194,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-11-21
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040194,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2019-11-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040195,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-11-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040195,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-11-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040195,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040195,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-11-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040196,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2019-09-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040196,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040196,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2019-11-15
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040196,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2019-11-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040197,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-09-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040197,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-11-08
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040197,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-11-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040197,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-11-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040198,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2019-10-16
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040198,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040198,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2019-11-19
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040198,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2019-11-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040199,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-11-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040199,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2019-11-23
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040199,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2019-11-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040199,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040200,Normal Issue,"
Received",2019-11-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040200,Normal Issue, Revised,2019-11-20
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040200,Normal Issue, Accepted,2019-11-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040200,Normal Issue, Published,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040201,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2019-11-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040201,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040201,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2019-11-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040202,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040202,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2019-11-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040202,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040202,"
(This article belongs to the Section Veterinary Vaccines)", Published,2019-11-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040203,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)","
Received",2019-10-31
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040203,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Revised,2019-11-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040203,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Accepted,2019-11-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040203,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Published,2019-12-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040204,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-11-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040204,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040204,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-11-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040204,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-12-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040205,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-11-07
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040205,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-11-25
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040205,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040205,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-12-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040206,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)","
Received",2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040206,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Revised,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040206,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Accepted,2019-11-29
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040206,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Published,2019-12-04
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040207,"
(This article belongs to the Special Issue Herpesvirus Vaccines)","
Received",2019-11-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040207,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Revised,2019-12-01
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040207,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Accepted,2019-12-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040207,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Published,2019-12-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040208,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2019-11-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040208,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2019-11-28
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040208,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2019-12-03
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040208,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2019-12-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040209,"
(This article belongs to the Section HIV Vaccines)","
Received",2019-11-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040209,"
(This article belongs to the Section HIV Vaccines)", Revised,2019-11-27
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040209,"
(This article belongs to the Section HIV Vaccines)", Accepted,2019-12-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040209,"
(This article belongs to the Section HIV Vaccines)", Published,2019-12-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040210,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2019-11-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040210,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2019-11-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040210,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2019-12-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040210,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2019-12-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040211,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)","
Received",2019-10-18
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040211,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Revised,2019-12-02
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040211,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Accepted,2019-12-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040211,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Published,2019-12-09
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040212,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2019-10-30
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040212,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2019-12-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040212,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2019-12-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040212,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2019-12-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040213,Normal Issue,"
Received",2019-10-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040213,Normal Issue, Revised,2019-12-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040213,Normal Issue, Accepted,2019-12-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040213,Normal Issue, Published,2019-12-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040214,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-11-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040214,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2019-12-06
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040214,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2019-12-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040214,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2019-12-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040215,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2019-11-22
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040215,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2019-12-05
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040215,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2019-12-11
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040215,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2019-12-13
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040216,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2019-11-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040216,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2019-12-10
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040216,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2019-12-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040216,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2019-12-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040217,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)","
Received",2019-11-26
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040217,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Revised,2019-12-12
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040217,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Accepted,2019-12-14
Vaccines,2019,7,4,https://doi.org/10.3390/vaccines7040217,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Published,2019-12-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010001,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2019-11-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010001,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Revised,2019-12-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010001,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2019-12-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010001,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2019-12-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010002,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-11-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010002,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010002,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2019-12-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010002,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010003,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-11-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010003,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010003,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2019-12-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010003,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010004,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2019-12-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010004,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2019-12-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010004,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010004,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010005,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010005,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010005,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2019-12-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010005,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010006,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-11-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010006,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010006,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010006,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2019-12-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010007,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2019-11-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010007,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2019-12-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010007,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2019-12-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010007,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2019-12-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010008,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)","
Received",2019-11-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010008,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Revised,2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010008,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Accepted,2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010008,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Published,2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010009,Normal Issue,"
Received",2019-12-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010009,Normal Issue, Revised,2019-12-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010009,Normal Issue, Accepted,2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010009,Normal Issue, Published,2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010010,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)","
Received",2019-11-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010010,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)", Revised,2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010010,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)", Accepted,2019-12-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010010,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)", Published,2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010011,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)","
Received",2019-12-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010011,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)", Revised,2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010011,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)", Accepted,2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010011,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)", Published,2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010012,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-12-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010012,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010012,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010012,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010013,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2019-11-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010013,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Revised,2019-12-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010013,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010013,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2020-01-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010014,"
(This article belongs to the Special Issue Herpesvirus Vaccines)","
Received",2019-10-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010014,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Revised,2019-10-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010014,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Accepted,2019-10-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010014,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Published,2020-01-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010015,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-11-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010015,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010015,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-01-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010015,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-01-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010016,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2019-12-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010016,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2019-12-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010016,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010016,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-01-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010017,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-11-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010017,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-01-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010017,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010017,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010018,Normal Issue,"
Received",2019-12-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010018,Normal Issue, Revised,2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010018,Normal Issue, Accepted,2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010018,Normal Issue, Published,2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010019,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-12-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010019,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2020-01-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010019,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010019,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010020,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010020,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010020,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010020,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010021,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-11-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010021,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-01-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010021,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-01-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010021,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010022,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2019-11-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010022,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010022,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010022,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-01-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010023,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2019-12-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010023,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010023,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010023,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-01-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010024,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2019-12-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010024,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010024,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010024,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010025,Normal Issue,"
Received",2019-12-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010025,Normal Issue, Revised,2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010025,Normal Issue, Accepted,2020-01-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010025,Normal Issue, Published,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010026,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010026,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010026,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010026,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010027,"
(This article belongs to the Special Issue Immunization by Electroporation)","
Received",2019-12-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010027,"
(This article belongs to the Special Issue Immunization by Electroporation)", Revised,2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010027,"
(This article belongs to the Special Issue Immunization by Electroporation)", Accepted,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010027,"
(This article belongs to the Special Issue Immunization by Electroporation)", Published,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010028,"
(This article belongs to the Section HIV Vaccines)","
Received",2019-12-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010028,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010028,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010028,"
(This article belongs to the Section HIV Vaccines)", Published,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010029,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2019-11-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010029,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010029,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-01-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010029,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010030,Normal Issue,"
Published",2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010031,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-12-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010031,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010031,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010031,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010032,Normal Issue,"
Received",2019-12-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010032,Normal Issue, Revised,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010032,Normal Issue, Accepted,2020-01-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010032,Normal Issue, Published,2020-01-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010033,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2019-12-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010033,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010033,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010033,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-01-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010034,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010034,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010034,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010034,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010035,"
(This article belongs to the Special Issue Herpesvirus Vaccines)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010035,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Revised,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010035,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Accepted,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010035,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Published,2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010036,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)","
Received",2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010036,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Revised,2020-01-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010036,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Accepted,2020-01-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010036,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Published,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010037,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-12-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010037,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-01-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010037,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010037,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010038,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)","
Received",2020-01-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010038,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Revised,2020-01-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010038,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Accepted,2020-01-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010038,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Published,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010039,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)","
Received",2019-12-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010039,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Revised,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010039,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Accepted,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010039,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Published,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010040,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-01-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010040,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010040,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010040,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010041,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010042,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010042,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-01-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010042,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010042,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010043,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)","
Received",2019-12-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010043,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Revised,2020-01-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010043,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Accepted,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010043,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Published,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010044,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)","
Received",2020-01-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010044,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Accepted,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010044,"
(This article belongs to the Special Issue Advances in Antibody-based HIV-1 Vaccine Development)", Published,2020-01-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010045,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-12-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010045,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-01-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010045,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010045,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-01-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010046,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-12-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010046,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010046,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010046,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-01-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010047,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010047,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010047,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010047,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010048,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)","
Received",2019-12-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010048,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Revised,2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010048,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Accepted,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010048,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Published,2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010049,"
(This article belongs to the Special Issue Immunization by Electroporation)","
Received",2019-12-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010049,"
(This article belongs to the Special Issue Immunization by Electroporation)", Revised,2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010049,"
(This article belongs to the Special Issue Immunization by Electroporation)", Accepted,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010049,"
(This article belongs to the Special Issue Immunization by Electroporation)", Published,2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010050,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)","
Received",2020-01-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010050,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Revised,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010050,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Accepted,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010050,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Published,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010051,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010051,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010051,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010051,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010052,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-01-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010052,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010052,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010052,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010053,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010053,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010053,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010054,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010054,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010054,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010054,"
(This article belongs to the Section HIV Vaccines)", Published,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010055,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010055,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010055,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010055,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010056,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-10-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010056,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2019-11-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010056,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010056,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010057,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010057,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010057,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010057,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010058,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010058,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010058,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010058,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010059,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-12-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010059,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010059,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010059,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010060,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010060,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010060,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010060,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-02-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010061,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2019-12-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010061,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-01-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010061,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010061,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-02-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010062,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2019-12-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010062,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Revised,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010062,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010062,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2020-02-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010063,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010063,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Revised,2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010063,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Accepted,2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010063,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Published,2020-02-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010064,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010064,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010064,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010064,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-02-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010065,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2019-11-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010065,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010065,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-02-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010065,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-02-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010066,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2019-12-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010066,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-01-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010066,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010066,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-02-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010067,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)","
Received",2019-12-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010067,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)", Revised,2020-02-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010067,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)", Accepted,2020-02-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010067,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)", Published,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010068,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010068,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-02-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010068,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-02-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010069,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2019-12-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010069,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-02-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010069,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010069,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010070,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2020-01-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010070,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010070,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010070,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010071,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010071,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010071,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010071,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010072,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010072,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010072,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010072,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010073,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)","
Received",2020-01-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010073,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Revised,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010073,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010073,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Published,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010074,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010074,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-02-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010074,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010074,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010075,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010075,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010075,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-02-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010075,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010076,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-12-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010076,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2020-01-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010076,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010076,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010077,Normal Issue,"
Received",2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010077,Normal Issue, Revised,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010077,Normal Issue, Accepted,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010077,Normal Issue, Published,2020-02-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010078,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010078,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010078,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010078,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-02-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010079,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-12-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010079,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-02-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010079,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010079,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010080,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-01-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010080,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010080,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010080,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010081,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010081,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010081,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010081,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010082,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2020-01-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010082,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2020-02-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010082,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010082,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010083,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-01-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010083,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-02-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010083,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010083,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010084,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2019-12-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010084,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-01-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010084,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010084,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010085,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2019-12-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010085,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-02-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010085,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010085,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010086,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010086,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010086,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-02-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010087,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010087,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010087,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010087,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-02-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010088,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-01-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010088,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2020-02-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010088,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010088,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-02-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010089,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)","
Received",2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010089,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Revised,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010089,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Accepted,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010089,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Published,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010090,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2019-12-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010090,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2020-01-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010090,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010090,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010091,Normal Issue,"
Received",2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010091,Normal Issue, Revised,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010091,Normal Issue, Accepted,2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010091,Normal Issue, Published,2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010092,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2020-01-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010092,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010092,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-02-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010092,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010093,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)","
Received",2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010093,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Revised,2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010093,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Accepted,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010093,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Published,2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010094,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)","
Received",2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010094,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Accepted,2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010094,"
(This article belongs to the Special Issue Arbovirus Vaccines That Circulate within the Same Ecological Niche: Zika, Dengue & Chikungunya)", Published,2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010095,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-02-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010095,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010095,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010095,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010096,Normal Issue,"
Received",2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010096,Normal Issue, Revised,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010096,Normal Issue, Accepted,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010096,Normal Issue, Published,2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010097,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010097,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010097,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010097,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010098,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)","
Received",2019-12-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010098,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Revised,2020-02-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010098,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Accepted,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010098,"
(This article belongs to the Special Issue Humanized Mice in Vaccinology: Opportunities and Challenges)", Published,2020-02-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010099,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010099,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010099,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010099,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-02-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010100,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-01-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010100,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010100,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010100,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010101,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2019-11-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010101,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2019-12-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010101,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010101,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010102,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010102,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010102,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010102,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010103,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010103,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010103,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-02-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010103,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-02-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010104,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010104,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010104,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-02-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010104,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010105,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)","
Received",2020-02-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010105,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Revised,2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010105,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Accepted,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010105,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Published,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010106,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2020-01-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010106,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Revised,2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010106,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2020-02-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010106,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010107,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-01-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010107,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010107,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010107,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-02-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010108,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-02-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010108,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010108,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010108,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-03-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010109,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-02-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010109,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-02-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010109,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010109,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-03-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010110,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)","
Received",2020-01-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010110,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)", Revised,2020-02-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010110,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)", Accepted,2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010110,"
(This article belongs to the Special Issue Nanotechnology in Vaccine)", Published,2020-03-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010111,"
(This article belongs to the Special Issue Immunization by Electroporation)","
Received",2020-01-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010111,"
(This article belongs to the Special Issue Immunization by Electroporation)", Revised,2020-02-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010111,"
(This article belongs to the Special Issue Immunization by Electroporation)", Accepted,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010111,"
(This article belongs to the Special Issue Immunization by Electroporation)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010112,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)","
Received",2020-01-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010112,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Revised,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010112,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Accepted,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010112,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010113,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010113,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010113,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010113,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010114,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-02-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010114,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-02-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010114,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010114,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010115,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)","
Received",2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010115,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Revised,2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010115,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Accepted,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010115,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010116,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-02-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010116,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-02-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010116,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-02-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010116,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010117,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010117,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-02-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010117,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010117,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010118,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-02-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010118,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010118,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-03-01
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010118,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-03-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010119,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2020-01-31
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010119,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010119,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-02-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010119,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-03-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010120,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-02-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010120,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010120,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-03
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010120,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-03-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010121,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-02-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010121,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-03-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010121,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-03-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010122,Normal Issue,"
Received",2020-02-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010122,Normal Issue, Revised,2020-03-05
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010122,Normal Issue, Accepted,2020-03-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010122,Normal Issue, Published,2020-03-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010123,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-02-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010123,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-03-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010123,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-03-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010123,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-03-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010124,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-01-25
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010124,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-02-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010124,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-02-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010124,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010125,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2020-01-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010125,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010125,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2020-03-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010125,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2020-03-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010126,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-02-02
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010126,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-03-07
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010126,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-03-08
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010126,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010127,Normal Issue,"
Received",2020-02-24
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010127,Normal Issue, Revised,2020-03-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010127,Normal Issue, Accepted,2020-03-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010127,Normal Issue, Published,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010128,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-02-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010128,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-03-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010128,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-03-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010128,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010129,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-02-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010129,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-03-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010129,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-03-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010129,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-03-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010130,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2019-12-11
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010130,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-01-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010130,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010130,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-03-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010131,Normal Issue,"
Received",2020-02-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010131,Normal Issue, Revised,2020-03-09
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010131,Normal Issue, Accepted,2020-03-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010131,Normal Issue, Published,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010132,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)","
Received",2019-12-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010132,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)", Revised,2020-02-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010132,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)", Accepted,2020-02-29
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010132,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches)", Published,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010133,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))","
Received",2020-02-26
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010133,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Revised,2020-03-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010133,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Accepted,2020-03-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010133,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Published,2020-03-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010134,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-02-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010134,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010134,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010134,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-03-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010135,"
(This article belongs to the Special Issue Immunization by Electroporation)","
Received",2020-01-30
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010135,"
(This article belongs to the Special Issue Immunization by Electroporation)", Revised,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010135,"
(This article belongs to the Special Issue Immunization by Electroporation)", Accepted,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010135,"
(This article belongs to the Special Issue Immunization by Electroporation)", Published,2020-03-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010136,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010136,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-03-12
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010136,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010136,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010137,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-02-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010137,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010137,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010137,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-03-19
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010138,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2020-02-27
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010138,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010138,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2020-03-18
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010138,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2020-03-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010139,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)","
Received",2020-02-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010139,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Revised,2020-03-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010139,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Accepted,2020-03-15
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010139,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Published,2020-03-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010140,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-01-28
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010140,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-03-14
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010140,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-03-17
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010140,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010141,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-03-06
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010141,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-03-20
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010141,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-03-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010141,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-03-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010142,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-02-04
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010142,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010142,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-03-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010142,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-03-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010143,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-02-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010143,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-03-13
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010143,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-03-16
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010143,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-03-23
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010144,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-10
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010144,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-21
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010144,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-22
Vaccines,2020,8,1,https://doi.org/10.3390/vaccines8010144,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-03-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-02-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2020-03-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-03-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020145,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-03-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020146,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-02-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020146,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-03-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020146,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-03-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020146,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020147,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-02-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020147,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-03-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020147,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-03-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020147,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020148,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-03-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020148,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-03-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020148,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020148,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020149,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-02-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020149,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020149,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-03-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020149,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020150,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-03-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020150,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020150,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020150,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020151,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-03-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020151,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020151,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020151,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-03-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020152,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-02-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020152,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-03-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020152,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-03-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020152,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-03-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020153,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020153,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020153,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020153,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-03-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020154,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2020-02-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020154,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Revised,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020154,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2020-03-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020154,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020155,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-02-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020155,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-03-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020155,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020155,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020156,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2020-03-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020156,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Revised,2020-03-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020156,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020156,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020157,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-03-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020157,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020157,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020157,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-04-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020158,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-02-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020158,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020158,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020158,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020159,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020159,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020159,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020159,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020160,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)","
Received",2020-02-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020160,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Revised,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020160,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Accepted,2020-04-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020160,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Published,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020161,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-03-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020161,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020161,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020161,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020162,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-03-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020162,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-03-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020162,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-04-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020162,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020163,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-03-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020163,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-04-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020163,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-04-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020163,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020164,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)","
Received",2020-02-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020164,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Revised,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020164,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Accepted,2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020164,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Published,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020165,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)","
Received",2020-02-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020165,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Revised,2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020165,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Accepted,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020165,"
(This article belongs to the Special Issue Infectious Diseases and Vaccinations in Healthcare Professionals)", Published,2020-04-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020166,"
(This article belongs to the Special Issue Immunization by Electroporation)","
Received",2020-01-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020166,"
(This article belongs to the Special Issue Immunization by Electroporation)", Revised,2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020166,"
(This article belongs to the Special Issue Immunization by Electroporation)", Accepted,2020-04-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020166,"
(This article belongs to the Special Issue Immunization by Electroporation)", Published,2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020167,Normal Issue,"
Received",2020-02-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020167,Normal Issue, Revised,2020-03-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020167,Normal Issue, Accepted,2020-03-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020167,Normal Issue, Published,2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020168,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)","
Received",2020-03-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020168,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Revised,2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020168,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Accepted,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020168,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Published,2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020169,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-03-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020169,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020169,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020169,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020170,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-03-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020170,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2020-03-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020170,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-03-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020170,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020171,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020171,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-04-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020171,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020171,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020172,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)","
Received",2020-02-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020172,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Revised,2020-03-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020172,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Accepted,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020172,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Published,2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020173,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2020-03-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020173,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2020-04-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020173,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2020-04-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020173,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020174,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)","
Received",2020-03-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020174,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Revised,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020174,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Accepted,2020-04-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020174,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Published,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-02-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020176,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-03-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020176,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020176,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020176,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020177,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))","
Received",2020-03-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020177,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Revised,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020177,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Accepted,2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020177,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Published,2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020178,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-03-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020178,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-04-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020178,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020178,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-04-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020179,"
(This article belongs to the Special Issue Herpesvirus Vaccines)","
Received",2020-03-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020179,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Revised,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020179,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Accepted,2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020179,"
(This article belongs to the Special Issue Herpesvirus Vaccines)", Published,2020-04-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020180,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-02-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020180,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020180,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020180,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020181,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-03-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020181,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020181,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-04-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020181,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020182,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-03-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020182,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020182,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020182,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020183,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)","
Received",2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020183,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)", Revised,2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020183,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)", Accepted,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020183,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)", Published,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020184,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020184,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020184,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-04-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020184,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020185,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-02-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020185,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020185,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020185,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020186,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-03-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020186,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-04-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020186,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-04-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020186,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020187,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-02-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020187,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020187,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020187,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020188,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2020-03-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020188,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020188,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020188,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020189,"
(This article belongs to the Section Cellular/Molecular Immunology)","
Received",2020-03-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020189,"
(This article belongs to the Section Cellular/Molecular Immunology)", Revised,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020189,"
(This article belongs to the Section Cellular/Molecular Immunology)", Accepted,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020189,"
(This article belongs to the Section Cellular/Molecular Immunology)", Published,2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020190,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020190,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020190,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020190,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-04-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020191,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-03-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020191,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-04-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020191,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020191,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-04-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020192,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))","
Received",2020-02-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020192,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Revised,2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020192,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Accepted,2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020192,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Published,2020-04-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020193,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-03-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020193,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020193,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020193,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020194,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020194,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-04-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020194,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020194,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020195,Normal Issue,"
Received",2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020195,Normal Issue, Revised,2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020195,Normal Issue, Accepted,2020-04-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020195,Normal Issue, Published,2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020196,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020196,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020196,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-04-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020196,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020197,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020197,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020197,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-04-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020197,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020198,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-03-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020198,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020198,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-04-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020198,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-04-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020199,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020199,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-04-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020199,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-04-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020199,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-04-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020200,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020200,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020200,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020200,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-04-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020201,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))","
Received",2020-03-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020201,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Revised,2020-04-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020201,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Accepted,2020-04-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020201,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Published,2020-04-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020202,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020202,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-04-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020202,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-04-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020202,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020203,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020203,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020203,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-04-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020203,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020204,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-03-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020204,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020204,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020204,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020205,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020205,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-04-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020205,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020205,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020206,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-03-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020206,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020206,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020206,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-04-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020207,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020207,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-04-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020207,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-04-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020207,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-05-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020208,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020208,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-04-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020208,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020208,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-05-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020209,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020209,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-05-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020209,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-05-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020209,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020210,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-03-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020210,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020210,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020210,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020211,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-04-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020211,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-05-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020211,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-05-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020211,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020212,Normal Issue,"
Received",2020-04-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020212,Normal Issue, Revised,2020-04-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020212,Normal Issue, Accepted,2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020212,Normal Issue, Published,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020213,"
(This article belongs to the Section Clinical Immunology)","
Received",2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020213,"
(This article belongs to the Section Clinical Immunology)", Revised,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020213,"
(This article belongs to the Section Clinical Immunology)", Accepted,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020213,"
(This article belongs to the Section Clinical Immunology)", Published,2020-05-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020214,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020214,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020214,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020214,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2020-05-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020215,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020215,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-05-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020215,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020215,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-05-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020216,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-03-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020216,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020216,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-04-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020216,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020217,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020217,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020217,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020217,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020218,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020218,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020218,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-05-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020218,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020219,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020219,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020219,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-05-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020219,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020220,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020220,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020220,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020220,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020221,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)","
Received",2020-03-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020221,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Revised,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020221,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Accepted,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020221,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Published,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020222,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020222,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020222,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020222,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020223,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
 Received",2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020223,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-05-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020223,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020223,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020224,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-04-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020224,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-05-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020224,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020224,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020225,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020225,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-05-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020225,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020225,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020226,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-03-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020226,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020226,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020226,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020227,"
(This article belongs to the Section Hepatitis Virus Vaccines)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020227,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Revised,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020227,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Accepted,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020227,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Published,2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020228,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)","
Received",2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020228,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)", Revised,2020-05-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020228,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)", Accepted,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020228,"
(This article belongs to the Special Issue Research in Bat-Borne Zoonotic Viruses)", Published,2020-05-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020229,"
(This article belongs to the Special Issue Immunity at the Gate of Entrance; Vaccines against Respiratory Viruses such as Influenza and RSV)","
Received",2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020229,"
(This article belongs to the Special Issue Immunity at the Gate of Entrance; Vaccines against Respiratory Viruses such as Influenza and RSV)", Revised,2020-05-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020229,"
(This article belongs to the Special Issue Immunity at the Gate of Entrance; Vaccines against Respiratory Viruses such as Influenza and RSV)", Accepted,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020229,"
(This article belongs to the Special Issue Immunity at the Gate of Entrance; Vaccines against Respiratory Viruses such as Influenza and RSV)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020230,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020230,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020230,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020230,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020231,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-04-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020231,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020231,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020231,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020232,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020232,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)", Revised,2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020232,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)", Accepted,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020232,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020233,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-04-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020233,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020233,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020233,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020234,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-04-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020234,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-05-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020234,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020234,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020235,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-03-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020235,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-05-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020235,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020235,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020236,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020236,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020236,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020236,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020237,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-04-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020237,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020237,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020237,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-05-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020238,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-04-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020238,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-05-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020238,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020238,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-05-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020239,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-05-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020239,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020239,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020239,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020240,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020240,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020240,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-05-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020240,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020241,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)","
Received",2020-04-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020241,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Revised,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020241,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Accepted,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020241,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Published,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020242,"
(This article belongs to the Section Vaccines and Society)","
Received",2020-04-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020242,"
(This article belongs to the Section Vaccines and Society)", Revised,2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020242,"
(This article belongs to the Section Vaccines and Society)", Accepted,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020242,"
(This article belongs to the Section Vaccines and Society)", Published,2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020243,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-04-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020243,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020243,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-05-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020243,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020244,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020244,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020244,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020244,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-05-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020245,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)","
Received",2020-04-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020245,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Revised,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020245,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Accepted,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020245,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Published,2020-05-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020246,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-04-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020246,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020246,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020246,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-05-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020247,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020247,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020247,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020247,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-05-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020248,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020248,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020248,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020248,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-05-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020249,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-02-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020249,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Revised,2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020249,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020249,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020250,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020250,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020250,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-05-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020250,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020251,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-04-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020251,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-05-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020251,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-05-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020251,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020252,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020252,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-03-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020252,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020252,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020253,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020253,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020253,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020253,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020254,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)","
Received",2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020254,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Revised,2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020254,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Accepted,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020254,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Published,2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020255,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-04-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020255,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020255,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020255,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020256,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020256,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020256,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020256,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020257,Normal Issue,"
Received",2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020257,Normal Issue, Revised,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020257,Normal Issue, Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020257,Normal Issue, Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020258,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020258,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Revised,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020258,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020258,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020259,"
(This article belongs to the Section Human Papillomavirus Vaccines)","
Received",2020-05-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020259,"
(This article belongs to the Section Human Papillomavirus Vaccines)", Revised,2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020259,"
(This article belongs to the Section Human Papillomavirus Vaccines)", Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020259,"
(This article belongs to the Section Human Papillomavirus Vaccines)", Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020260,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-05-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020260,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-05-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020260,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020260,"
(This article belongs to the Section HIV Vaccines)", Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020261,"
 (This article belongs to the Section Vaccine Adjuvants)","
Received",2020-03-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020261,"
 (This article belongs to the Section Vaccine Adjuvants)", Revised,2020-05-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020261,"
 (This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020261,"
 (This article belongs to the Section Vaccine Adjuvants)", Published,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020262,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-04-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020262,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020262,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020262,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-05-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020263,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-03-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020263,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-05-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020263,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020263,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-05-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020264,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020264,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-05-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020264,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020264,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-05-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020265,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020265,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020265,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020265,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020266,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)","
Received",2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020266,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Revised,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020266,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Accepted,2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020266,"
(This article belongs to the Special Issue Update on Flavivirus Vaccines)", Published,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020267,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-03-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020267,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020267,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020267,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020268,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-04-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020268,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020268,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020269,"
(This article belongs to the Section Pathogens-host Immune Interface)","
Received",2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020269,"
(This article belongs to the Section Pathogens-host Immune Interface)", Revised,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020269,"
(This article belongs to the Section Pathogens-host Immune Interface)", Accepted,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020269,"
(This article belongs to the Section Pathogens-host Immune Interface)", Published,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020270,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-03-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020270,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020270,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020270,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020271,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020271,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020271,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-05-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020271,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020272,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020272,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020272,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020272,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020273,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-05-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020273,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020273,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020273,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020274,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020274,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020274,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020274,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020275,"
(This article belongs to the Section Hepatitis Virus Vaccines)","
Received",2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020275,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Revised,2020-04-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020275,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Accepted,2020-04-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020275,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Published,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020276,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020276,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020276,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020276,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020277,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020277,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020277,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020277,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020278,Normal Issue,"
Received",2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020278,Normal Issue, Revised,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020278,Normal Issue, Accepted,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020278,Normal Issue, Published,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020279,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)","
Received",2020-04-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020279,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Revised,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020279,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Accepted,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020279,"
(This article belongs to the Section Therapeutic Vaccines and Antibody Therapeutics)", Published,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020280,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020280,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020280,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020280,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020281,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020281,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-05-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020281,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020281,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020282,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-03-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020282,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020282,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020282,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020283,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020283,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020283,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020283,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020284,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020284,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020284,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020284,"
(This article belongs to the Section HIV Vaccines)", Published,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020285,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-05-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020285,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020285,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020285,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-06-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020286,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020286,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020286,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020286,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020287,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020287,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020287,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020287,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020288,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-04-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020288,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020288,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020288,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020289,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020289,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020289,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020289,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020290,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2020-05-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020290,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2020-05-31
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020290,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2020-06-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020290,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020291,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020291,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-05-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020291,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020291,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020292,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020292,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020292,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020292,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020293,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-05-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020293,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020293,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020293,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020294,"
(This article belongs to the Section Hepatitis Virus Vaccines)","
Received",2020-04-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020294,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Revised,2020-05-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020294,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Accepted,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020294,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Published,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020295,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)","
Received",2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020295,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)", Revised,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020295,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)", Accepted,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020295,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)", Published,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020296,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-05-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020296,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-05-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020296,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020296,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020297,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)","
Received",2020-05-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020297,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Revised,2020-06-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020297,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Accepted,2020-06-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020297,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Published,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020298,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2020-04-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020298,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020298,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020298,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020299,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-04-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020299,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-06-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020299,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020299,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020300,Normal Issue,"
Received",2020-05-07
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020300,Normal Issue, Revised,2020-05-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020300,Normal Issue, Accepted,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020300,Normal Issue, Published,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020301,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)","
Received",2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020301,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Revised,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020301,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Accepted,2020-06-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020301,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Published,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020302,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-05-05
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020302,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020302,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020302,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020303,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)","
Received",2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020303,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)", Revised,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020303,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)", Accepted,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020303,"
(This article belongs to the Special Issue Pattern Recognition Receptors for Bacteria and Fungi and the Innate Immune Response)", Published,2020-06-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020304,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020304,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-06-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020304,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020304,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020305,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2019-09-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020305,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2019-11-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020305,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020306,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-05-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020306,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020306,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020306,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020307,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020307,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020307,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020307,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020308,"
(This article belongs to the Section Clinical Immunology)","
Received",2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020308,"
(This article belongs to the Section Clinical Immunology)", Revised,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020308,"
(This article belongs to the Section Clinical Immunology)", Accepted,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020308,"
(This article belongs to the Section Clinical Immunology)", Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020309,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020309,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020309,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-06-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020309,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020310,Normal Issue,"
Received",2020-04-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020310,Normal Issue, Revised,2020-05-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020310,Normal Issue, Accepted,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020310,Normal Issue, Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020311,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-05-03
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020311,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020311,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020311,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020312,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-04-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020312,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020312,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020312,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020313,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-06-01
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020313,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020313,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020313,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020314,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2020-05-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020314,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020314,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020314,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020315,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020315,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020315,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020315,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020316,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020316,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020316,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020316,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020317,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-05-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020317,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020317,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020317,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020318,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020318,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020318,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-06-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020318,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020319,Normal Issue,"
Received",2020-04-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020319,Normal Issue, Revised,2020-05-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020319,Normal Issue, Accepted,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020319,Normal Issue, Published,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020320,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)","
Received",2020-05-28
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020320,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)", Revised,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020320,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020320,"
(This article belongs to the Section Toxicology Studies and Clinical Trials)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020321,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-05-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020321,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020321,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020321,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020322,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-05-02
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020322,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-06-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020322,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020322,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020323,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020323,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-06-12
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020323,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020323,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020324,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)","
Received",2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020324,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Revised,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020324,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020324,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020325,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)","
Received",2020-05-27
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020325,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Revised,2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020325,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020325,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020326,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-05-06
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020326,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-06-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020326,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020326,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020327,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-04-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020327,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-11
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020327,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020327,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020328,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-05-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020328,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-06-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020328,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020328,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020329,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2020-04-30
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020329,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020329,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-06-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020329,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-06-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020330,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020330,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020330,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-06-21
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020330,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-06-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020331,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-06-09
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020331,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020331,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-19
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020331,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020332,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020332,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-06-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020332,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020332,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-06-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020333,"
(This article belongs to the Section Cellular/Molecular Immunology)","
Received",2020-05-16
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020333,"
(This article belongs to the Section Cellular/Molecular Immunology)", Revised,2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020333,"
(This article belongs to the Section Cellular/Molecular Immunology)", Accepted,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020333,"
(This article belongs to the Section Cellular/Molecular Immunology)", Published,2020-06-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020334,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)","
Received",2020-05-13
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020334,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Revised,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020334,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020334,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Published,2020-06-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020335,Normal Issue,"
Received",2020-05-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020335,Normal Issue, Revised,2020-06-04
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020335,Normal Issue, Accepted,2020-06-17
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020335,Normal Issue, Published,2020-06-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020336,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-06-08
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020336,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-06-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020336,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-06-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020336,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-06-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020337,Normal Issue,"
Received",2020-05-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020337,Normal Issue, Revised,2020-06-14
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020337,Normal Issue, Accepted,2020-06-18
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020337,Normal Issue, Published,2020-06-25
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020338,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-05-29
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020338,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-06-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020338,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-06-22
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020338,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020339,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-05-15
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020339,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-06-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020339,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-06-24
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020339,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-06-26
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020340,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-05-10
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020340,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2020-06-20
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020340,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2020-06-23
Vaccines,2020,8,2,https://doi.org/10.3390/vaccines8020340,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030341,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-04-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030341,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-05-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030341,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-05-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030341,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030342,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030342,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030342,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030342,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030343,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-04-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030343,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030343,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030343,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030344,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-06-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030344,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030344,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030344,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-06-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030345,Normal Issue,"
Received",2020-06-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030345,Normal Issue, Revised,2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030345,Normal Issue, Accepted,2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030345,Normal Issue, Published,2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030346,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030346,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030346,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030346,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030347,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-04-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030347,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-05-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030347,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-06-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030347,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030348,Normal Issue,"
Received",2020-06-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030348,Normal Issue, Revised,2020-06-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030348,Normal Issue, Accepted,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030348,Normal Issue, Published,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030349,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-05-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030349,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030349,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-06-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030349,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030350,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-05-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030350,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030350,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-06-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030350,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030351,"
(This article belongs to the Special Issue Human Leukocyte Antigen (HLA) and Vaccines)","
Received",2020-06-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030351,"
(This article belongs to the Special Issue Human Leukocyte Antigen (HLA) and Vaccines)", Revised,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030351,"
(This article belongs to the Special Issue Human Leukocyte Antigen (HLA) and Vaccines)", Accepted,2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030351,"
(This article belongs to the Special Issue Human Leukocyte Antigen (HLA) and Vaccines)", Published,2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030352,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-06-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030352,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030352,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-06-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030352,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030353,Normal Issue,"
Received",2020-05-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030353,Normal Issue, Revised,2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030353,Normal Issue, Accepted,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030353,Normal Issue, Published,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030354,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-06-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030354,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030354,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030354,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030355,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-05-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030355,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030355,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030355,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030356,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)","
Received",2020-06-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030356,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Revised,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030356,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Accepted,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030356,"
(This article belongs to the Special Issue Feature Papers Collection on Influenza Vaccines)", Published,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030357,Normal Issue,"
Received",2020-05-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030357,Normal Issue, Revised,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030357,Normal Issue, Accepted,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030357,Normal Issue, Published,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030358,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-05-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030358,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030358,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030358,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-07-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030359,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-06-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030359,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030359,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030359,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-07-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030360,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-06-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030360,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030360,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030360,"
(This article belongs to the Section HIV Vaccines)", Published,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030361,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030361,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030361,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030361,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030362,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030362,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-06-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030362,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030362,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030363,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-06-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030363,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030363,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030363,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030364,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)","
Received",2020-05-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030364,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Revised,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030364,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Accepted,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030364,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Published,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030365,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-06-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030365,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030365,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030365,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030366,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-05-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030366,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030366,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-06-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030366,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030367,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))","
Received",2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030367,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Accepted,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030367,"
(This article belongs to the Special Issue Pathobiology of Respiratory Syncytial Virus (RSV))", Published,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030368,Normal Issue,"
Received",2020-06-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030368,Normal Issue, Revised,2020-07-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030368,Normal Issue, Accepted,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030368,Normal Issue, Published,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030369,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-05-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030369,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030369,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030369,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030370,Normal Issue,"
Received",2020-05-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030370,Normal Issue, Revised,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030370,Normal Issue, Accepted,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030370,Normal Issue, Published,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030371,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-06-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030371,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-06-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030371,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-06-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030371,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030372,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-06-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030372,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030372,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030372,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030373,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-06-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030373,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030373,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030373,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030374,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030374,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030374,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030374,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030375,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030375,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030375,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030375,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030376,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030376,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030376,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030377,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-06-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030377,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030377,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030377,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030378,"
 (This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-06-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030378,"
 (This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030378,"
 (This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030378,"
 (This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030379,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2020-06-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030379,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2020-07-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030379,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030379,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030380,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-05-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030380,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030380,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030380,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030381,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-06-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030381,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030381,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030381,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030382,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-06-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030382,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030382,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030382,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-07-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030383,"
(This article belongs to the Section Epidemiology)","
Received",2020-06-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030383,"
(This article belongs to the Section Epidemiology)", Revised,2020-06-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030383,"
(This article belongs to the Section Epidemiology)", Accepted,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030383,"
(This article belongs to the Section Epidemiology)", Published,2020-07-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030384,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-06-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030384,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-06-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030384,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030384,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030385,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)","
Received",2020-06-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030385,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Revised,2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030385,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Accepted,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030385,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Published,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030386,Normal Issue,"
Received",2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030386,Normal Issue, Revised,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030386,Normal Issue, Accepted,2020-07-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030386,Normal Issue, Published,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030387,"
(This article belongs to the Section Vaccines and Society)","
Received",2020-06-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030387,"
(This article belongs to the Section Vaccines and Society)", Revised,2020-07-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030387,"
(This article belongs to the Section Vaccines and Society)", Accepted,2020-07-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030387,"
(This article belongs to the Section Vaccines and Society)", Published,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030388,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030388,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-07-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030388,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030388,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030389,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2020-06-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030389,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030389,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030389,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030390,Normal Issue,"
Received",2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030390,Normal Issue, Accepted,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030390,Normal Issue, Published,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030391,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030391,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030391,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030391,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030392,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-05-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030392,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-06-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030392,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030392,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-07-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030393,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-05-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030393,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-06-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030393,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030393,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030394,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030394,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-07-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030394,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030394,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030395,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2020-06-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030395,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030395,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030395,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030396,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)","
Received",2020-05-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030396,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Revised,2020-07-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030396,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Accepted,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030396,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030397,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-05-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030397,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030397,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-07-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030397,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030398,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-06-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030398,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030398,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030398,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030399,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-06-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030399,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-07-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030399,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030399,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030400,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-05-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030400,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030400,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030400,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030401,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)","
Received",2020-06-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030401,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Revised,2020-07-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030401,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Accepted,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030401,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Published,2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030402,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-06-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030402,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030402,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2020-07-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030402,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030403,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030403,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030403,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030403,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030404,Normal Issue,"
Received",2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030404,Normal Issue, Revised,2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030404,Normal Issue, Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030404,Normal Issue, Published,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030405,"
(This article belongs to the Section Vaccines and Society)","
Received",2020-06-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030405,"
(This article belongs to the Section Vaccines and Society)", Revised,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030405,"
(This article belongs to the Section Vaccines and Society)", Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030405,"
(This article belongs to the Section Vaccines and Society)", Published,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030406,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-05-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030406,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030406,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030406,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030407,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-06-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030407,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Revised,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030407,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030407,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030408,Normal Issue,"
Received",2020-06-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030408,Normal Issue, Revised,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030408,Normal Issue, Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030408,Normal Issue, Published,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030409,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-06-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030409,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030409,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030409,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030410,Normal Issue,"
Received",2020-06-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030410,Normal Issue, Revised,2020-07-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030410,Normal Issue, Accepted,2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030410,Normal Issue, Published,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030411,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-06-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030411,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-07-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030411,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030411,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030412,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-02-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030412,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-05-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030412,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-06-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030412,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030413,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-05-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030413,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-06-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030413,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-06-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030413,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030414,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-03-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030414,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-04-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030414,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-04-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030414,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030415,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)","
Received",2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030415,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Revised,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030415,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030415,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Published,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030416,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-06-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030416,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-07-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030416,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030416,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030417,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-05-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030417,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-06-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030417,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030417,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030418,Normal Issue,"
Received",2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030418,Normal Issue, Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030418,Normal Issue, Published,2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030419,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)","
Received",2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030419,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Revised,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030419,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Accepted,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030419,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Published,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030420,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030420,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030420,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030420,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030421,Normal Issue,"
Received",2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030421,Normal Issue, Accepted,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030421,Normal Issue, Published,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030422,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-07-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030422,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030422,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030422,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030423,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-06-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030423,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030423,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030423,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030424,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030424,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030424,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030424,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030425,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030425,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030425,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030425,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030426,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030426,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030426,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030426,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030427,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030427,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-07-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030427,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030427,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030428,Normal Issue,"
Received",2020-07-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030428,Normal Issue, Revised,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030428,Normal Issue, Accepted,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030428,Normal Issue, Published,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030429,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-05-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030429,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030429,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030429,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030430,Normal Issue,"
Received",2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030430,Normal Issue, Accepted,2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030430,Normal Issue, Published,2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030431,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030431,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030431,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030431,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030432,Normal Issue,"
Received",2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030432,Normal Issue, Accepted,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030432,Normal Issue, Published,2020-08-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030433,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-06-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030433,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030433,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030433,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030434,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-06-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030434,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030434,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030434,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030435,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-06-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030435,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-07-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030435,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030435,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030436,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-04-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030436,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-05-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030436,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-05-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030436,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030437,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-07-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030437,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030437,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030437,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030438,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)","
Received",2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030438,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Revised,2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030438,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Accepted,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030438,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Published,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030439,Normal Issue,"
Received",2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030439,Normal Issue, Accepted,2020-08-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030439,Normal Issue, Published,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030440,"
(This article belongs to the Section Hepatitis Virus Vaccines)","
Received",2020-06-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030440,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Revised,2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030440,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Accepted,2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030440,"
(This article belongs to the Section Hepatitis Virus Vaccines)", Published,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030441,Normal Issue,"
Received",2020-06-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030441,Normal Issue, Revised,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030441,Normal Issue, Accepted,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030441,Normal Issue, Published,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030442,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)","
Received",2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030442,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Revised,2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030442,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Accepted,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030442,"
(This article belongs to the Special Issue Therapeutic Vaccination of HIV-infected Patients)", Published,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030443,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030443,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030443,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030443,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030444,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-06-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030444,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030444,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030444,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030445,Normal Issue,"
Received",2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030445,Normal Issue, Accepted,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030445,Normal Issue, Published,2020-08-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030446,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-07-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030446,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-08-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030446,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030446,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-08-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030447,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-07-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030447,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-08-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030447,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030447,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-08-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030448,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030448,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030448,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030448,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-08-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030449,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030449,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-07-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030449,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030449,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-08-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030450,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030450,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030450,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-08-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030451,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-07-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030451,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030451,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-08-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030451,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030452,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-07-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030452,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-08-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030452,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-08-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030452,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030453,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2020-07-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030453,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2020-08-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030453,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030453,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030454,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030454,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-08-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030454,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030454,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030455,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)","
Received",2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030455,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Revised,2020-08-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030455,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Accepted,2020-08-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030455,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Published,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030456,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030456,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-08-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030456,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030456,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-08-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030457,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030457,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030457,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030457,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030458,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030458,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-08-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030458,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030458,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030459,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030459,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030459,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030459,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030460,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)","
Received",2020-07-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030460,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Revised,2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030460,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Accepted,2020-08-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030460,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Published,2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030461,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030461,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030461,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030461,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030462,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)","
Received",2020-06-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030462,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)", Revised,2020-08-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030462,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)", Accepted,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030462,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)", Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030463,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-06-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030463,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030463,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030463,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030464,Normal Issue,"
Received",2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030464,Normal Issue, Revised,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030464,Normal Issue, Accepted,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030464,Normal Issue, Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030465,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)","
Received",2020-07-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030465,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Revised,2020-08-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030465,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Accepted,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030465,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030466,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-07-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030466,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030466,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-08-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030466,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030467,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030467,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030467,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-08-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030467,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030468,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)","
Received",2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030468,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)", Revised,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030468,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)", Accepted,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030468,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)", Published,2020-08-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030469,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030469,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-08-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030469,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030469,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-08-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030470,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)","
Received",2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030470,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Revised,2020-08-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030470,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Accepted,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030470,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Published,2020-08-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030471,Normal Issue,"
Received",2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030471,Normal Issue, Revised,2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030471,Normal Issue, Accepted,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030471,Normal Issue, Published,2020-08-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030472,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030472,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030472,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2020-08-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030472,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030473,"
(This article belongs to the Section Human Papillomavirus Vaccines)","
Received",2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030473,"
(This article belongs to the Section Human Papillomavirus Vaccines)", Revised,2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030473,"
(This article belongs to the Section Human Papillomavirus Vaccines)", Accepted,2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030473,"
(This article belongs to the Section Human Papillomavirus Vaccines)", Published,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030474,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030474,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-08-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030474,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-08-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030474,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030475,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-07-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030475,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030475,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030475,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030476,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)","
Received",2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030476,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Revised,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030476,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Accepted,2020-08-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030476,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Published,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030477,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )","
Received",2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030477,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Accepted,2020-08-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030477,"
(This article belongs to the Special Issue Current Flavivirus Research Important for Vaccine Development )", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030478,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030478,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Revised,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030478,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030478,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030479,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)","
Received",2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030479,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Accepted,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030479,"
(This article belongs to the Special Issue Vaccines against RNA Viruses)", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030480,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)","
Received",2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030480,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Revised,2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030480,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Accepted,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030480,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030481,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2020-07-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030481,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030481,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030481,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030482,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030482,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030482,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030482,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030483,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)","
Received",2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030483,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Revised,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030483,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Accepted,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030483,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Published,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030484,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)","
Received",2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030484,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Revised,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030484,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Accepted,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030484,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Published,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030485,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030485,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-08-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030485,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030485,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030486,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)","
Received",2020-07-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030486,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Revised,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030486,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Accepted,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030486,"
(This article belongs to the Special Issue Biotechnology of Non-disease Prevention Vaccines)", Published,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030487,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)","
Received",2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030487,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Revised,2020-08-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030487,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Accepted,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030487,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Published,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030488,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-07-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030488,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030488,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030488,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-08-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030489,Normal Issue,"
Received",2020-07-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030489,Normal Issue, Revised,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030489,Normal Issue, Accepted,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030489,Normal Issue, Published,2020-08-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030490,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030490,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030490,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030490,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030491,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)","
Received",2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030491,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Revised,2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030491,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Accepted,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030491,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Published,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030492,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030492,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-08-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030492,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-08-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030492,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030493,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)","
Received",2020-06-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030493,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Revised,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030493,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Accepted,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030493,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Published,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030494,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030494,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030494,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030494,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030495,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2020-07-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030495,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030495,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030495,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030496,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2020-08-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030496,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030496,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030496,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030497,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-07-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030497,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030497,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030497,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030498,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2020-07-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030498,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030498,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030498,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030499,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030499,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030499,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-08-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030499,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030500,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)","
Received",2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030500,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Revised,2020-08-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030500,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Accepted,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030500,"
(This article belongs to the Special Issue Strategies Addressing Falling Vaccine Coverage and Vaccine Hesitancy)", Published,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030501,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)","
Received",2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030501,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Revised,2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030501,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Accepted,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030501,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Published,2020-09-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030502,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030502,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030502,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030502,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2020-09-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030503,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030503,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030503,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030503,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030504,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030504,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030504,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030504,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030505,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030505,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030505,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030506,"
(This article belongs to the Special Issue Antibody against Viral Infection: Advances in the Era of Therapeutic Monoclonal Antibody)","
Received",2020-07-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030506,"
(This article belongs to the Special Issue Antibody against Viral Infection: Advances in the Era of Therapeutic Monoclonal Antibody)", Revised,2020-08-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030506,"
(This article belongs to the Special Issue Antibody against Viral Infection: Advances in the Era of Therapeutic Monoclonal Antibody)", Accepted,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030506,"
(This article belongs to the Special Issue Antibody against Viral Infection: Advances in the Era of Therapeutic Monoclonal Antibody)", Published,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030507,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-08-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030507,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030507,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030507,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-09-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030508,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)","
Received",2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030508,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Revised,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030508,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Accepted,2020-09-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030508,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Published,2020-09-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030509,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2020-07-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030509,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Revised,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030509,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2020-09-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030509,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2020-09-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030510,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-07-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030510,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030510,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030510,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030511,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030511,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030511,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030511,"
(This article belongs to the Section HIV Vaccines)", Published,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030512,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2020-07-30
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030512,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030512,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030512,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030513,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-06-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030513,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-08-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030513,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030513,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030514,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030514,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030514,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030514,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030515,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)","
Received",2020-08-03
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030515,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Revised,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030515,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Accepted,2020-09-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030515,"
(This article belongs to the Section Failed Vaccines and Vaccine Antigens)", Published,2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030516,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030516,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030516,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030516,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030517,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030517,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-09-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030517,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-09-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030517,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030518,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030518,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030518,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030518,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030519,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-08-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030519,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030519,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030519,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030520,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030520,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030520,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030520,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030521,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030521,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030521,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030521,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030522,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)","
Received",2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030522,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Accepted,2020-09-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030522,"
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)", Published,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030523,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-08-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030523,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-09-07
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030523,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030523,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-09-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030524,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030524,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030524,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030524,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-09-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030525,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)","
Received",2020-08-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030525,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)", Revised,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030525,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030525,"
(This article belongs to the Special Issue Immunomodulatory Plants & Plant-Derived Immunomodulators)", Published,2020-09-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030526,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)","
Received",2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030526,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Accepted,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030526,"
(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)", Published,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030527,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030527,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030527,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030527,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030528,"
(This article belongs to the Section Cellular/Molecular Immunology)","
Received",2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030528,"
(This article belongs to the Section Cellular/Molecular Immunology)", Revised,2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030528,"
(This article belongs to the Section Cellular/Molecular Immunology)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030528,"
(This article belongs to the Section Cellular/Molecular Immunology)", Published,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030529,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030529,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030529,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-09-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030529,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030530,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-08-28
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030530,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030530,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030530,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030531,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030531,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-09-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030531,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030531,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030532,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)","
Received",2020-07-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030532,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Revised,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030532,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Accepted,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030532,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Published,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030533,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)","
Received",2020-09-02
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030533,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Revised,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030533,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Accepted,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030533,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Published,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030534,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030534,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-09-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030534,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-09-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030534,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030535,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030535,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030535,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030535,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030536,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030536,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-09-10
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030536,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030536,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030537,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)","
Received",2020-07-09
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030537,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)", Revised,2020-08-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030537,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)", Accepted,2020-09-01
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030537,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)", Published,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030538,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)","
Received",2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030538,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Revised,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030538,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Accepted,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030538,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Published,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030539,Normal Issue,"
Received",2020-07-08
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030539,Normal Issue, Revised,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030539,Normal Issue, Accepted,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030539,Normal Issue, Published,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030540,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-08-31
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030540,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030540,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030540,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030541,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-08-05
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030541,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030541,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030541,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030542,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)","
Received",2020-06-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030542,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Revised,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030542,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Accepted,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030542,"
(This article belongs to the Special Issue Investigating Gametogenesis and Cancer for Discovering New Immunotherapeutic Targets)", Published,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030543,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030543,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030543,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030543,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030544,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030544,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030544,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030544,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030545,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)","
Received",2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030545,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030545,"
(This article belongs to the Special Issue Vaccination and Vaccine Effectiveness)", Published,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030546,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-08-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030546,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030546,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-09-17
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030546,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-09-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030547,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030547,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030547,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030547,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-09-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030548,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-08-19
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030548,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-11
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030548,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030548,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-09-20
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030549,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-08-27
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030549,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030549,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030549,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-09-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030550,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-07-23
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030550,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030550,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030550,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-09-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030551,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)","
Received",2020-08-26
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030551,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Revised,2020-09-14
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030551,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030551,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Published,2020-09-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030552,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)","
Received",2020-08-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030552,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)", Revised,2020-09-12
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030552,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030552,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)", Published,2020-09-21
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030553,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-08-24
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030553,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030553,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030553,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-09-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030554,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)","
Received",2020-08-25
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030554,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Revised,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030554,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Accepted,2020-09-18
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030554,"
(This article belongs to the Special Issue Immunological Mechanisms of Vaccines and Adjuvants)", Published,2020-09-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030555,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-08-04
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030555,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-13
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030555,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-09-16
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030555,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-09-22
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030556,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)","
Received",2020-07-29
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030556,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Revised,2020-09-06
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030556,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Accepted,2020-09-15
Vaccines,2020,8,3,https://doi.org/10.3390/vaccines8030556,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Published,2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040557,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)","
Received",2020-08-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040557,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Revised,2020-09-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040557,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Accepted,2020-09-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040557,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Published,2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040558,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)","
Received",2020-08-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040558,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Revised,2020-09-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040558,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Accepted,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040558,"
(This article belongs to the Special Issue Virus Immune Escape and Host Immune System)", Published,2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040559,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-07-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040559,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-09-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040559,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040559,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040560,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040560,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040560,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040560,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040561,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)","
Received",2020-08-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040561,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Revised,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040561,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Accepted,2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040561,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Published,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040562,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-09-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040562,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040562,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040562,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040563,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)","
Received",2020-07-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040563,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)", Revised,2020-09-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040563,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)", Accepted,2020-09-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040563,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040564,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-08-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040564,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040564,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040564,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040565,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-08-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040565,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040565,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040565,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040566,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040566,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040566,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040566,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040567,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-09-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040567,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040567,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040567,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040568,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)","
Received",2020-09-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040568,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Revised,2020-09-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040568,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Accepted,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040568,"
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040569,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2020-09-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040569,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040569,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040569,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040570,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-08-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040570,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040570,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040570,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040571,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-09-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040571,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040571,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-09-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040571,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040572,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-08-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040572,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040572,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040572,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040573,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-08-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040573,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-09-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040573,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040573,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040574,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)","
Received",2020-08-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040574,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Revised,2020-09-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040574,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Accepted,2020-09-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040574,"
(This article belongs to the Special Issue Viral Imprinting and Vaccine Design of Influenza and Other Viruses)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040575,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-09-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040575,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040575,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040575,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040576,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2020-09-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040576,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040576,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040576,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040577,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-09-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040577,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040577,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040577,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040578,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)","
Received",2020-08-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040578,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)", Revised,2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040578,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040578,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)", Published,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040579,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-08-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040579,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-09-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040579,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040579,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040580,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-06-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040580,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040580,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040580,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040581,"
(This article belongs to the Section Vaccines and Society)","
Received",2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040581,"
(This article belongs to the Section Vaccines and Society)", Revised,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040581,"
(This article belongs to the Section Vaccines and Society)", Accepted,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040581,"
(This article belongs to the Section Vaccines and Society)", Published,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040582,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040582,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040582,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040582,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040583,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)","
Received",2020-08-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040583,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Revised,2020-09-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040583,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Accepted,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040583,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Published,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040584,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-08-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040584,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040584,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040584,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040585,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-08-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040585,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040585,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040585,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040586,"

(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2020-09-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040586,"

(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040586,"

(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040586,"

(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040587,"
(This article belongs to the Special Issue Molecular Mechanisms of Viral Entry)","
Received",2020-09-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040587,"
(This article belongs to the Special Issue Molecular Mechanisms of Viral Entry)", Revised,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040587,"
(This article belongs to the Special Issue Molecular Mechanisms of Viral Entry)", Accepted,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040587,"
(This article belongs to the Special Issue Molecular Mechanisms of Viral Entry)", Published,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040588,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)","
Received",2020-09-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040588,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Revised,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040588,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Accepted,2020-10-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040588,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Published,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040589,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-09-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040589,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040589,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040589,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040590,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040590,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040590,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040590,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040591,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040591,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040591,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040592,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)","
Received",2020-09-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040592,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Revised,2020-09-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040592,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Accepted,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040592,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Published,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040593,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040593,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040593,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040593,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040594,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-08-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040594,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-09-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040594,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040594,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040595,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-09-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040595,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040595,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040595,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040596,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)","
Received",2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040596,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Revised,2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040596,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Accepted,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040596,"
(This article belongs to the Special Issue Therapeutic Vaccines and Cancer Immunotherapy)", Published,2020-10-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040597,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-07-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040597,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040597,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040597,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-10-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040598,Normal Issue,"
Received",2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040598,Normal Issue, Accepted,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040598,Normal Issue, Published,2020-10-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040599,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040599,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040599,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040599,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040600,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040600,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040600,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040600,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040601,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040601,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040601,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040602,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-09-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040602,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-10-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040602,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040602,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040603,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)","
Received",2020-08-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040603,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Revised,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040603,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Accepted,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040603,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Published,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040604,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2020-08-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040604,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040604,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040604,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040605,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)","
Received",2020-09-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040605,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Revised,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040605,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Accepted,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040605,"
(This article belongs to the Special Issue Avian Influenza Virus: New Strategies to Elicit Immune Responses and to Prevent and Control Infection)", Published,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040606,Normal Issue,"
Received",2020-08-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040606,Normal Issue, Revised,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040606,Normal Issue, Accepted,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040606,Normal Issue, Published,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040607,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040607,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040607,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040607,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040608,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2020-09-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040608,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040608,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040608,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040609,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-09-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040609,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040609,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040609,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040610,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040610,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040610,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040610,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040611,Normal Issue,"
Received",2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040611,Normal Issue, Revised,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040611,Normal Issue, Accepted,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040611,Normal Issue, Published,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040612,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-09-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040612,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040612,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040612,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040613,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)","
Received",2020-07-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040613,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)", Revised,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040613,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)", Accepted,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040613,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)", Published,2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040614,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)","
Received",2020-09-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040614,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Revised,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040614,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Accepted,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040614,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Published,2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040615,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040615,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Revised,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040615,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040615,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-10-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040616,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)","
Received",2020-09-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040616,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)", Revised,2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040616,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)", Accepted,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040616,"
(This article belongs to the Special Issue The Immunology of Hepatocellular Carcinoma: Towards the Future of Immunotherapy)", Published,2020-10-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040617,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040617,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040617,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040617,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-10-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040618,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-09-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040618,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040618,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040618,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040619,Normal Issue,"
Received",2020-08-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040619,Normal Issue, Revised,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040619,Normal Issue, Accepted,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040619,Normal Issue, Published,2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040620,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-09-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040620,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040620,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-10-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040620,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040621,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040621,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040621,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040621,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040622,Normal Issue,"
Received",2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040622,Normal Issue, Accepted,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040622,Normal Issue, Published,2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040623,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040623,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040623,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040623,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040624,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040624,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040624,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040624,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-10-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040625,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-09-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040625,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040625,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040625,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-10-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040626,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-08-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040626,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-10-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040626,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040626,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-10-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040627,"
(This article belongs to the Section Pathogens-host Immune Interface)","
Received",2020-01-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040627,"
(This article belongs to the Section Pathogens-host Immune Interface)", Revised,2020-03-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040627,"
(This article belongs to the Section Pathogens-host Immune Interface)", Accepted,2020-03-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040627,"
(This article belongs to the Section Pathogens-host Immune Interface)", Published,2020-10-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040628,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040628,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040628,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040628,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040629,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-08-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040629,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040629,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040629,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040630,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-09-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040630,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040630,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040630,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040631,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)","
Received",2020-08-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040631,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)", Revised,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040631,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)", Accepted,2020-10-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040631,"
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment)", Published,2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040632,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040632,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040632,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040632,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040633,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040633,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040633,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040633,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040634,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040634,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040634,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040634,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-11-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040635,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040635,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-10-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040635,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040635,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-11-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040636,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040636,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2020-10-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040636,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040636,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040637,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040637,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040637,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040637,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040638,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)","
Received",2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040638,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Revised,2020-10-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040638,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040638,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040639,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040639,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040639,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040639,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040640,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)","
Received",2020-06-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040640,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Revised,2020-09-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040640,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Accepted,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040640,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040641,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-09-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040641,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-10-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040641,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040641,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040642,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040642,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040642,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040642,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040643,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)","
Received",2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040643,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Revised,2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040643,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040643,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Published,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040644,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040644,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040644,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040644,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040645,Normal Issue,"
Received",2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040645,Normal Issue, Accepted,2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040645,Normal Issue, Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040646,"
(This article belongs to the Special Issue Microbial Antigen Delivery 2.0)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040646,"
(This article belongs to the Special Issue Microbial Antigen Delivery 2.0)", Revised,2020-10-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040646,"
(This article belongs to the Special Issue Microbial Antigen Delivery 2.0)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040646,"
(This article belongs to the Special Issue Microbial Antigen Delivery 2.0)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040647,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040647,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040647,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040647,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040648,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040648,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040648,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040648,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040649,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-09-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040649,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-10-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040649,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040649,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040650,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-07-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040650,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-09-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040650,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040650,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040651,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)","
Received",2020-09-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040651,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Revised,2020-10-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040651,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040651,"
(This article belongs to the Special Issue Vaccine Candidates against Tropical Diseases)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040652,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-09-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040652,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040652,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-10-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040652,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040653,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)","
Received",2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040653,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Accepted,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040653,"
(This article belongs to the Special Issue Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development)", Published,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040654,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2020-09-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040654,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2020-10-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040654,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040654,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040655,"
(This article belongs to the Special Issue Therapeutic Vaccine against Cancer)","
Received",2020-08-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040655,"
(This article belongs to the Special Issue Therapeutic Vaccine against Cancer)", Revised,2020-10-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040655,"
(This article belongs to the Special Issue Therapeutic Vaccine against Cancer)", Accepted,2020-10-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040655,"
(This article belongs to the Special Issue Therapeutic Vaccine against Cancer)", Published,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040656,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)","
Received",2020-10-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040656,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Revised,2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040656,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Accepted,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040656,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Published,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040657,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040657,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040657,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040657,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040658,"
(This article belongs to the Special Issue Immunopharmacology: Developing Immunomodulation and Immunotherapy Strategies for Tumors and Inflammatory Disorders)","
Received",2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040658,"
(This article belongs to the Special Issue Immunopharmacology: Developing Immunomodulation and Immunotherapy Strategies for Tumors and Inflammatory Disorders)", Revised,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040658,"
(This article belongs to the Special Issue Immunopharmacology: Developing Immunomodulation and Immunotherapy Strategies for Tumors and Inflammatory Disorders)", Accepted,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040658,"
(This article belongs to the Special Issue Immunopharmacology: Developing Immunomodulation and Immunotherapy Strategies for Tumors and Inflammatory Disorders)", Published,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040659,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040659,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-10-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040659,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040659,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040660,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-08-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040660,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040660,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-10-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040660,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040661,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040661,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040661,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040661,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040662,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040662,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Revised,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040662,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Accepted,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040662,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Published,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040663,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-10-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040663,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040663,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040663,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-11-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040664,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2020-08-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040664,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040664,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040664,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2020-11-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040665,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040665,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040665,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040665,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040666,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)","
Received",2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040666,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Revised,2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040666,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Accepted,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040666,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Published,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040667,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040667,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040667,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040667,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040668,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-10-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040668,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040668,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040668,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040669,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040669,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-10-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040669,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040669,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040670,"
(This article belongs to the Special Issue Cancer Vaccine)","
Received",2020-10-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040670,"
(This article belongs to the Special Issue Cancer Vaccine)", Revised,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040670,"
(This article belongs to the Special Issue Cancer Vaccine)", Accepted,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040670,"
(This article belongs to the Special Issue Cancer Vaccine)", Published,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040671,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-08-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040671,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040671,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040671,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040672,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040672,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040672,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040672,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2020-11-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040673,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040673,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040673,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040673,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040674,"
(This article belongs to the Section Epidemiology)","
Received",2020-09-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040674,"
(This article belongs to the Section Epidemiology)", Revised,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040674,"
(This article belongs to the Section Epidemiology)", Accepted,2020-11-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040674,"
(This article belongs to the Section Epidemiology)", Published,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040675,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040675,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040675,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040675,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040676,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040676,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040676,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040676,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040677,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)","
Received",2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040677,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)", Revised,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040677,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)", Accepted,2020-11-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040677,"
(This article belongs to the Special Issue Advances in Parasite Vaccines)", Published,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040678,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040678,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040678,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2020-11-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040678,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040679,Normal Issue,"
Received",2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040679,Normal Issue, Revised,2020-11-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040679,Normal Issue, Accepted,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040679,Normal Issue, Published,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040680,"
(This article belongs to the Special Issue Vaccines for Zoonotic, High-Consequence Pathogens: A One Health Approach to Disease Control)","
Received",2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040680,"
(This article belongs to the Special Issue Vaccines for Zoonotic, High-Consequence Pathogens: A One Health Approach to Disease Control)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040680,"
(This article belongs to the Special Issue Vaccines for Zoonotic, High-Consequence Pathogens: A One Health Approach to Disease Control)", Accepted,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040680,"
(This article belongs to the Special Issue Vaccines for Zoonotic, High-Consequence Pathogens: A One Health Approach to Disease Control)", Published,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040681,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040681,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040681,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2020-11-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040681,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040682,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040682,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040682,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040682,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040683,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040683,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040683,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2020-11-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040683,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040684,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040684,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040684,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040684,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040685,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-10-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040685,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040685,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-11-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040685,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040686,"
(This article belongs to the Special Issue Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases)","
Received",2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040686,"
(This article belongs to the Special Issue Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases)", Revised,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040686,"
(This article belongs to the Special Issue Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases)", Accepted,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040686,"
(This article belongs to the Special Issue Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040687,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040687,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040687,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040687,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040688,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)","
Received",2020-09-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040688,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)", Revised,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040688,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)", Accepted,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040688,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040689,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)","
Received",2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040689,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Revised,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040689,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Accepted,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040689,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Published,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040690,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040690,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-11-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040690,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040690,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040691,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040691,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040691,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040691,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040692,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040692,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040692,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040692,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040693,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040693,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040693,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040693,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040694,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)","
Received",2020-09-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040694,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Revised,2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040694,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Accepted,2020-10-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040694,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Published,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040695,Normal Issue,"
Received",2020-09-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040695,Normal Issue, Revised,2020-10-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040695,Normal Issue, Accepted,2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040695,Normal Issue, Published,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040696,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-11-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040696,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-11-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040696,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-11-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040696,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040697,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040697,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040697,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040697,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040698,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-10-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040698,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-11-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040698,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040698,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040699,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)","
Received",2020-10-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040699,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Revised,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040699,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Accepted,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040699,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Published,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040700,"
(This article belongs to the Section Immune Mechanisms)","
Received",2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040700,"
(This article belongs to the Section Immune Mechanisms)", Revised,2020-11-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040700,"
(This article belongs to the Section Immune Mechanisms)", Accepted,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040700,"
(This article belongs to the Section Immune Mechanisms)", Published,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040701,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-10-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040701,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-11-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040701,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040701,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040702,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)","
Received",2020-10-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040702,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)", Revised,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040702,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)", Accepted,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040702,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)", Published,2020-11-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040703,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040703,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040703,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040703,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040704,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)","
Received",2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040704,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Revised,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040704,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Accepted,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040704,"
(This article belongs to the Special Issue Vaccinology of Influenza Infection)", Published,2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040705,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040705,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040705,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040705,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040706,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040706,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040706,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040706,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040707,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2020-10-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040707,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040707,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040707,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040708,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040708,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-11-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040708,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040708,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040709,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)","
Received",2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040709,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Revised,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040709,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Accepted,2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040709,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Published,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040710,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040710,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040710,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-11-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040710,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040711,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040711,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040711,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040711,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040712,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)","
Received",2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040712,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Revised,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040712,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040712,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040713,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-10-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040713,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040713,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040713,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040714,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-09-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040714,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040714,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040714,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040715,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)","
Received",2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040715,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Revised,2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040715,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Accepted,2020-11-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040715,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040716,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-10-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040716,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040716,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040716,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040717,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)","
Received",2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040717,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Revised,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040717,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Accepted,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040717,"
(This article belongs to the Special Issue Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040718,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)","
Received",2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040718,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Revised,2020-11-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040718,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040718,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040719,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040719,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040719,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040719,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040720,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)","
Received",2020-10-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040720,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)", Revised,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040720,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)", Accepted,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040720,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040721,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-10-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040721,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040721,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040721,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040722,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)","
Received",2020-10-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040722,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Revised,2020-11-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040722,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Accepted,2020-11-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040722,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040723,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040723,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040723,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040723,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040724,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-11-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040724,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040724,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040724,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040725,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)","
Received",2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040725,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Revised,2020-11-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040725,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040725,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040726,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)","
Received",2020-10-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040726,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)", Revised,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040726,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040726,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040727,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)","
Received",2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040727,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Revised,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040727,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040727,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040728,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)","
Received",2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040728,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Revised,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040728,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Accepted,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040728,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040729,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)","
Received",2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040729,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Revised,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040729,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Accepted,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040729,"
(This article belongs to the Special Issue Next-Generation Pertussis Vaccines)", Published,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040730,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040730,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040730,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040730,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040731,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)","
Received",2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040731,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Revised,2020-11-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040731,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Accepted,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040731,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Published,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040732,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040732,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040732,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040732,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040733,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040733,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-11-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040733,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040733,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040734,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-10-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040734,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040734,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-11-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040734,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040735,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040735,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040735,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040735,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040736,Normal Issue,"
Received",2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040736,Normal Issue, Revised,2020-11-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040736,Normal Issue, Accepted,2020-11-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040736,Normal Issue, Published,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040737,"
(This article belongs to the Special Issue Advances in DNA Vaccines)","
Received",2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040737,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Accepted,2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040737,"
(This article belongs to the Special Issue Advances in DNA Vaccines)", Published,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040738,Normal Issue,"
Received",2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040738,Normal Issue, Accepted,2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040738,Normal Issue, Published,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040739,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2020-11-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040739,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040739,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040739,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2020-12-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040740,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)","
Received",2020-10-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040740,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Revised,2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040740,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Accepted,2020-11-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040740,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Published,2020-12-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040741,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-10-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040741,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040741,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040741,"
(This article belongs to the Section HIV Vaccines)", Published,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040742,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040742,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040742,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040742,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040743,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)","
Received",2020-10-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040743,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Revised,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040743,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Accepted,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040743,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Published,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040744,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040744,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-11-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040744,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040744,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-12-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040745,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040745,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2020-12-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040745,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040745,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040746,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040746,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040746,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2020-12-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040746,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040747,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)","
Received",2020-11-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040747,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)", Revised,2020-11-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040747,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)", Accepted,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040747,"
(This article belongs to the Special Issue Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases)", Published,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040748,"
(This article belongs to the Special Issue West Nile Virus Disease)","
Received",2020-10-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040748,"
(This article belongs to the Special Issue West Nile Virus Disease)", Revised,2020-12-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040748,"
(This article belongs to the Special Issue West Nile Virus Disease)", Accepted,2020-12-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040748,"
(This article belongs to the Special Issue West Nile Virus Disease)", Published,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040749,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-11-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040749,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-12-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040749,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-12-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040749,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040750,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-11-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040750,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-12-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040750,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040750,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040751,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)","
Received",2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040751,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)", Revised,2020-12-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040751,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)", Accepted,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040751,"
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)", Published,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040752,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040752,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040752,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-11-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040752,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040753,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-29
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040753,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-12-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040753,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040753,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040754,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040754,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040754,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040754,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040755,"
(This article belongs to the Section Vaccine Adjuvants)","
Received",2020-10-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040755,"
(This article belongs to the Section Vaccine Adjuvants)", Revised,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040755,"
(This article belongs to the Section Vaccine Adjuvants)", Accepted,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040755,"
(This article belongs to the Section Vaccine Adjuvants)", Published,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040756,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-11-03
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040756,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-11-26
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040756,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040756,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-12-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040757,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-11-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040757,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-12-08
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040757,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040757,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-12-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040758,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040758,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040758,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040758,"
(This article belongs to the Section HIV Vaccines)", Published,2020-12-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040759,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2020-11-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040759,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2020-11-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040759,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040759,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040760,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040760,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040760,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040760,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040761,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)","
Received",2020-11-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040761,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Revised,2020-12-06
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040761,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Accepted,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040761,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Published,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040762,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040762,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040762,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2020-12-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040762,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040763,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-09-01
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040763,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-12-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040763,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-12-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040763,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040764,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-10-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040764,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040764,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040764,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040765,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2020-11-04
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040765,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040765,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040765,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2020-12-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040766,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)","
Received",2020-11-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040766,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Revised,2020-11-28
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040766,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Accepted,2020-12-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040766,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Published,2020-12-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040767,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-11-07
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040767,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-12-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040767,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040767,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040768,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)","
Received",2020-11-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040768,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Revised,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040768,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Accepted,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040768,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Published,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040769,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)","
Received",2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040769,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Revised,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040769,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Accepted,2020-12-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040769,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Published,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040770,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-09-23
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040770,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2020-11-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040770,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040770,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040771,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2020-11-05
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040771,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2020-12-12
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040771,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2020-12-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040771,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040772,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)","
Received",2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040772,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Revised,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040772,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Accepted,2020-12-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040772,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Published,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040773,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2020-11-27
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040773,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040773,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040773,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040774,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-10-31
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040774,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-12-09
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040774,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-12-15
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040774,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-12-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040775,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-10-30
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040775,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2020-12-02
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040775,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040775,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2020-12-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040776,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2020-11-22
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040776,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040776,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040776,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2020-12-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040777,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)","
Received",2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040777,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Revised,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040777,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Accepted,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040777,"
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)", Published,2020-12-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040778,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)","
Received",2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040778,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Revised,2020-12-10
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040778,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Accepted,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040778,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Published,2020-12-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040779,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)","
Received",2020-11-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040779,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Revised,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040779,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Accepted,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040779,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Published,2020-12-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040780,"
(This article belongs to the Special Issue Perspective Technologies of Vaccination and Immunotherapy)","
Received",2020-11-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040780,"
(This article belongs to the Special Issue Perspective Technologies of Vaccination and Immunotherapy)", Revised,2020-12-11
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040780,"
(This article belongs to the Special Issue Perspective Technologies of Vaccination and Immunotherapy)", Accepted,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040780,"
(This article belongs to the Special Issue Perspective Technologies of Vaccination and Immunotherapy)", Published,2020-12-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040781,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040781,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-12-16
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040781,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-12-17
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040781,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2020-12-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040782,"
(This article belongs to the Section HIV Vaccines)","
Received",2020-11-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040782,"
(This article belongs to the Section HIV Vaccines)", Revised,2020-12-19
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040782,"
(This article belongs to the Section HIV Vaccines)", Accepted,2020-12-20
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040782,"
(This article belongs to the Section HIV Vaccines)", Published,2020-12-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040783,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2020-11-25
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040783,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2020-12-13
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040783,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040783,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2020-12-21
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040784,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-11-24
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040784,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2020-12-14
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040784,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2020-12-18
Vaccines,2020,8,4,https://doi.org/10.3390/vaccines8040784,"
(This article belongs to the Section Veterinary Vaccines)", Published,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010001,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)","
Received",2020-11-20
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010001,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)", Revised,2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010001,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)", Accepted,2020-12-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010001,"
(This article belongs to the Special Issue Recent Advances in Mucosal Vaccines)", Published,2020-12-22
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010002,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-12-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010002,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010002,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2020-12-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010002,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2020-12-22
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010003,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2020-12-01
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010003,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010003,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2020-12-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010003,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010004,"
(This article belongs to the Special Issue Lumpy Skin Disease Control and Vaccines)","
Received",2020-11-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010004,"
(This article belongs to the Special Issue Lumpy Skin Disease Control and Vaccines)", Revised,2020-12-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010004,"
(This article belongs to the Special Issue Lumpy Skin Disease Control and Vaccines)", Accepted,2020-12-22
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010004,"
(This article belongs to the Special Issue Lumpy Skin Disease Control and Vaccines)", Published,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010005,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)","
Received",2020-10-27
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010005,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)", Revised,2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010005,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)", Accepted,2020-12-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010005,"
(This article belongs to the Special Issue Tick-Vaccine and Tick-Control)", Published,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010006,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-11-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010006,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2020-12-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010006,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2020-12-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010006,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010007,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)","
Received",2020-09-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010007,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Revised,2020-10-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010007,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Accepted,2020-10-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010007,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Published,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010008,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)","
Received",2020-11-25
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010008,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)", Revised,2020-12-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010008,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)", Accepted,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010008,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)", Published,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010009,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)","
Received",2020-11-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010009,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Accepted,2020-12-01
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010009,"
(This article belongs to the Special Issue Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World)", Published,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010010,"
(This article belongs to the Special Issue Clinical Effect and Immunologic Response after Dendritic Cell-Based Immunotherapy)","
Received",2020-11-25
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010010,"
(This article belongs to the Special Issue Clinical Effect and Immunologic Response after Dendritic Cell-Based Immunotherapy)", Revised,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010010,"
(This article belongs to the Special Issue Clinical Effect and Immunologic Response after Dendritic Cell-Based Immunotherapy)", Accepted,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010010,"
(This article belongs to the Special Issue Clinical Effect and Immunologic Response after Dendritic Cell-Based Immunotherapy)", Published,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010011,Normal Issue,"
Received",2020-10-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010011,Normal Issue, Revised,2020-12-03
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010011,Normal Issue, Accepted,2020-12-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010011,Normal Issue, Published,2020-12-25
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010012,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)","
Received",2020-07-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010012,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Revised,2020-08-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010012,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Accepted,2020-08-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010012,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Published,2020-12-26
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010013,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2020-11-27
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010013,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2020-12-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010013,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2020-12-20
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010013,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2020-12-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010014,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2020-11-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010014,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010014,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010014,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2020-12-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010015,Normal Issue,"
Received",2020-11-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010015,Normal Issue, Revised,2020-12-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010015,Normal Issue, Accepted,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010015,Normal Issue, Published,2020-12-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010016,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)","
Received",2020-12-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010016,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Revised,2020-12-22
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010016,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Accepted,2020-12-29
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010016,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Published,2020-12-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010017,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)","
Received",2020-11-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010017,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Revised,2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010017,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Accepted,2020-12-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010017,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Published,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010018,Normal Issue,"
Received",2020-11-27
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010018,Normal Issue, Revised,2020-12-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010018,Normal Issue, Accepted,2020-12-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010018,Normal Issue, Published,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010019,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-12-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010019,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010019,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2020-12-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010019,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010020,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)","
Received",2020-10-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010020,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Revised,2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010020,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Accepted,2020-12-29
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010020,"
(This article belongs to the Special Issue Immunology and Immunopathology of Poultry and Livestock Infectious Diseases)", Published,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010021,Normal Issue,"
Received",2020-12-09
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010021,Normal Issue, Revised,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010021,Normal Issue, Accepted,2020-12-31
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010021,Normal Issue, Published,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010022,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)","
Received",2020-12-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010022,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Revised,2020-12-29
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010022,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Accepted,2020-12-31
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010022,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Published,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010023,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)","
Received",2020-12-03
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010023,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Revised,2020-12-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010023,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Accepted,2021-01-01
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010023,"
(This article belongs to the Special Issue Treatment of Orthopoxvirus Infections)", Published,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010024,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-11-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010024,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010024,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2021-01-02
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010024,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010025,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-11-09
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010025,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010025,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010025,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010026,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-12-24
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010026,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010026,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010026,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010027,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)","
Received",2020-11-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010027,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Revised,2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010027,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Accepted,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010027,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Published,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010028,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010028,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-01-03
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010028,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010028,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010029,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-11-26
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010029,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2021-01-02
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010029,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010029,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010030,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)","
Received",2020-12-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010030,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Revised,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010030,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Accepted,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010030,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Published,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010031,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010031,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2021-01-03
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010031,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010031,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010032,"
(This article belongs to the Special Issue Mosquito-Borne Viruses: Fundamental Biology and Therapeutic Intervention)","
Received",2020-11-25
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010032,"
(This article belongs to the Special Issue Mosquito-Borne Viruses: Fundamental Biology and Therapeutic Intervention)", Revised,2020-12-28
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010032,"
(This article belongs to the Special Issue Mosquito-Borne Viruses: Fundamental Biology and Therapeutic Intervention)", Accepted,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010032,"
(This article belongs to the Special Issue Mosquito-Borne Viruses: Fundamental Biology and Therapeutic Intervention)", Published,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010033,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)","
Received",2020-12-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010033,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Revised,2021-01-02
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010033,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Accepted,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010033,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Published,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010034,"
(This article belongs to the Special Issue Vaccines for Aquaculture)","
Received",2020-11-25
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010034,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Revised,2020-12-31
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010034,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Accepted,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010034,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Published,2021-01-09
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010035,"
(This article belongs to the Special Issue Peptide Trends in Immunology and Infectious Diseases: Therapeutics, Diagnostics and (Bio)materials)","
Received",2020-12-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010035,"
(This article belongs to the Special Issue Peptide Trends in Immunology and Infectious Diseases: Therapeutics, Diagnostics and (Bio)materials)", Revised,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010035,"
(This article belongs to the Special Issue Peptide Trends in Immunology and Infectious Diseases: Therapeutics, Diagnostics and (Bio)materials)", Accepted,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010035,"
(This article belongs to the Special Issue Peptide Trends in Immunology and Infectious Diseases: Therapeutics, Diagnostics and (Bio)materials)", Published,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010036,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)","
Received",2020-12-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010036,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Revised,2020-12-31
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010036,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Accepted,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010036,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Published,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010037,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010037,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010037,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010037,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010038,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)","
Received",2021-01-03
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010038,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Revised,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010038,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Accepted,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010038,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Published,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010039,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2020-11-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010039,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2021-01-02
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010039,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010039,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010040,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)","
Received",2020-12-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010040,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Revised,2021-01-01
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010040,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Accepted,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010040,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Published,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010041,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)","
Received",2020-11-29
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010041,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Revised,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010041,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010041,"
(This article belongs to the Special Issue Fish Cells Involved in Antiviral Immune Response)", Published,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010042,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)","
Received",2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010042,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Revised,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010042,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010042,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Published,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010043,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-11-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010043,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010043,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010043,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010044,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-11-29
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010044,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010044,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010044,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010045,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)","
Received",2020-11-20
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010045,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Revised,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010045,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010045,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Published,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010046,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2020-12-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010046,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2021-01-04
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010046,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010046,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010047,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-12-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010047,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010047,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010047,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010048,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)","
Received",2020-12-22
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010048,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Revised,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010048,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Accepted,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010048,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010049,"
(This article belongs to the Special Issue Rabies Vaccination and Immunotherapy)","
Received",2020-12-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010049,"
(This article belongs to the Special Issue Rabies Vaccination and Immunotherapy)", Revised,2021-01-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010049,"
(This article belongs to the Special Issue Rabies Vaccination and Immunotherapy)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010049,"
(This article belongs to the Special Issue Rabies Vaccination and Immunotherapy)", Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010050,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2020-12-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010050,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010050,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010050,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010051,Normal Issue,"
Received",2020-11-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010051,Normal Issue, Revised,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010051,Normal Issue, Accepted,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010051,Normal Issue, Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010052,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)","
Received",2020-12-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010052,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)", Revised,2021-01-03
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010052,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)", Accepted,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010052,"
(This article belongs to the Special Issue Research on Development of Norovirus Vaccines)", Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010053,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-12-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010053,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-01-06
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010053,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010053,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010054,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-12-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010054,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010054,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010054,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2021-01-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010055,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-12-07
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010055,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010055,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010055,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-01-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010056,"
(This article belongs to the Special Issue Dendritic Cell Immunotherapies: An Opportunity in the Fight against Cancer and Beyond)","
Received",2020-12-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010056,"
(This article belongs to the Special Issue Dendritic Cell Immunotherapies: An Opportunity in the Fight against Cancer and Beyond)", Revised,2021-01-05
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010056,"
(This article belongs to the Special Issue Dendritic Cell Immunotherapies: An Opportunity in the Fight against Cancer and Beyond)", Accepted,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010056,"
(This article belongs to the Special Issue Dendritic Cell Immunotherapies: An Opportunity in the Fight against Cancer and Beyond)", Published,2021-01-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010057,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2020-12-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010057,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-01-08
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010057,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010057,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-01-16
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010058,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)","
Received",2020-11-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010058,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Revised,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010058,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Accepted,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010058,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Published,2021-01-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010059,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)","
Received",2020-12-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010059,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Accepted,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010059,"
(This article belongs to the Special Issue Strategic Approaches to Vaccine Design Against Negative Strand Virus Diseases)", Published,2021-01-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010060,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)","
Received",2020-12-21
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010060,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Revised,2021-01-09
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010060,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Accepted,2021-01-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010060,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Published,2021-01-17
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010061,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2020-12-23
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010061,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010061,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010061,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-01-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010062,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-12-02
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010062,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2021-01-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010062,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010062,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2021-01-18
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010063,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2020-11-30
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010063,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2021-01-02
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010063,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2021-01-13
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010063,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2021-01-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010064,"
(This article belongs to the Special Issue Tumor Immunotherapy)","
Received",2020-12-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010064,"
(This article belongs to the Special Issue Tumor Immunotherapy)", Revised,2021-01-10
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010064,"
(This article belongs to the Special Issue Tumor Immunotherapy)", Accepted,2021-01-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010064,"
(This article belongs to the Special Issue Tumor Immunotherapy)", Published,2021-01-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010065,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2020-12-27
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010065,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010065,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-01-14
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010065,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-01-19
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010066,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)","
Received",2020-12-12
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010066,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Revised,2021-01-11
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010066,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Accepted,2021-01-15
Vaccines,2021,9,1,https://doi.org/10.3390/vaccines9010066,"
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)", Published,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020067,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)","
Received",2020-12-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020067,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Revised,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020067,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Accepted,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020067,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Published,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020068,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-11-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020068,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020068,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020068,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020069,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)","
Received",2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020069,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Revised,2021-01-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020069,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Accepted,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020069,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Published,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020070,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2020-12-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020070,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020070,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020070,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020071,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020071,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2021-01-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020071,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020071,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020072,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)","
Received",2020-12-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020072,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Revised,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020072,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Accepted,2021-01-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020072,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Published,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020073,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-12-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020073,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020073,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-01-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020073,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020074,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2020-12-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020074,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2021-01-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020074,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020074,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020075,"
(This article belongs to the Special Issue Antibodies in Influenza Vaccine and Therapeutic Design)","
Received",2020-12-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020075,"
(This article belongs to the Special Issue Antibodies in Influenza Vaccine and Therapeutic Design)", Revised,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020075,"
(This article belongs to the Special Issue Antibodies in Influenza Vaccine and Therapeutic Design)", Accepted,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020075,"
(This article belongs to the Special Issue Antibodies in Influenza Vaccine and Therapeutic Design)", Published,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020076,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)","
Received",2020-12-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020076,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Revised,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020076,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Accepted,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020076,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Published,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020077,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)","
Received",2020-12-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020077,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Revised,2021-01-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020077,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Accepted,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020077,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Published,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020078,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2020-12-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020078,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2021-01-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020078,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020078,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020079,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2020-12-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020079,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020079,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020079,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020080,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2020-12-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020080,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2021-01-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020080,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2021-01-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020080,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020081,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2021-01-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020081,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020081,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020081,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020082,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)","
Received",2020-12-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020082,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Revised,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020082,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020082,"
(This article belongs to the Special Issue Timely Administration of the Hepatitis B Birth Dose Vaccine)", Published,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020083,"
(This article belongs to the Special Issue Human Papillomavirus Vaccine against Cervical Cancer and Beyond: Opportunities, Challenges and New Perspectives)","
Received",2020-12-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020083,"
(This article belongs to the Special Issue Human Papillomavirus Vaccine against Cervical Cancer and Beyond: Opportunities, Challenges and New Perspectives)", Revised,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020083,"
(This article belongs to the Special Issue Human Papillomavirus Vaccine against Cervical Cancer and Beyond: Opportunities, Challenges and New Perspectives)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020083,"
(This article belongs to the Special Issue Human Papillomavirus Vaccine against Cervical Cancer and Beyond: Opportunities, Challenges and New Perspectives)", Published,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020084,"
(This article belongs to the Section Epidemiology)","
Received",2020-12-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020084,"
(This article belongs to the Section Epidemiology)", Revised,2021-01-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020084,"
(This article belongs to the Section Epidemiology)", Accepted,2021-01-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020084,"
(This article belongs to the Section Epidemiology)", Published,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020085,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)","
Received",2020-12-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020085,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)", Revised,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020085,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020085,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)", Published,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020086,"
(This article belongs to the Special Issue Vaccines for Aquaculture)","
Received",2020-12-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020086,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Revised,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020086,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020086,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Published,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020087,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020087,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020087,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020087,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020088,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)","
Received",2020-12-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020088,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Revised,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020088,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Accepted,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020088,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Published,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020089,Normal Issue,"
Published",2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020090,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2021-01-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020090,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020090,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020090,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020091,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2020-12-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020091,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020091,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020091,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020092,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)","
Received",2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020092,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)", Revised,2021-01-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020092,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)", Accepted,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020092,"
(This article belongs to the Special Issue Vaccines in Small Ruminants)", Published,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020093,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2020-12-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020093,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-01-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020093,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020093,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020094,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-12-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020094,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020094,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020094,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020095,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)","
Received",2020-12-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020095,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Revised,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020095,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Accepted,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020095,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Published,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020096,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)","
Received",2020-12-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020096,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Revised,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020096,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Accepted,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020096,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Published,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020097,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2020-12-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020097,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020097,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020097,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020098,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2021-01-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020098,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2021-01-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020098,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2021-01-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020098,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020099,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)","
Received",2021-01-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020099,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Revised,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020099,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Accepted,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020099,"
(This article belongs to the Special Issue Multiple Sclerosis and Its Complications: Clinical Trials)", Published,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020100,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)","
Received",2020-11-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020100,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Revised,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020100,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Accepted,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020100,"
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)", Published,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020101,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2021-01-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020101,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2021-01-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020101,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020101,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020102,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-11-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020102,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2021-01-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020102,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020102,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020103,Normal Issue,"
Received",2021-01-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020103,Normal Issue, Revised,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020103,Normal Issue, Accepted,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020103,Normal Issue, Published,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020104,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2020-12-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020104,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2021-01-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020104,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020104,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020105,"
(This article belongs to the Special Issue From Fundamental Biology to Translational Medicine: Block Host-Pathogen Interaction to Prevent Onset of Infectious Diseases)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020105,"
(This article belongs to the Special Issue From Fundamental Biology to Translational Medicine: Block Host-Pathogen Interaction to Prevent Onset of Infectious Diseases)", Revised,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020105,"
(This article belongs to the Special Issue From Fundamental Biology to Translational Medicine: Block Host-Pathogen Interaction to Prevent Onset of Infectious Diseases)", Accepted,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020105,"
(This article belongs to the Special Issue From Fundamental Biology to Translational Medicine: Block Host-Pathogen Interaction to Prevent Onset of Infectious Diseases)", Published,2021-01-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020106,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)","
Received",2020-12-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020106,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Revised,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020106,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Accepted,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020106,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Published,2021-01-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020107,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2020-12-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020107,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020107,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020107,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2021-01-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020108,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2021-01-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020108,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020108,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020108,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-01-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020109,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)","
Received",2020-12-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020109,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Revised,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020109,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Accepted,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020109,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Published,2021-02-01
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020110,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2020-12-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020110,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020110,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020110,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-02-01
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020111,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020111,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020111,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020111,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020112,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2020-12-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020112,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020112,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020112,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020113,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2021-01-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020113,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020113,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020113,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020114,Normal Issue,"
Received",2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020114,Normal Issue, Accepted,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020114,Normal Issue, Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020115,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020115,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020115,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020115,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020116,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020116,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020116,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020116,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020117,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)","
Received",2020-12-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020117,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Revised,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020117,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Accepted,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020117,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Published,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020118,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-12-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020118,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020118,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020118,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020119,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)","
Received",2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020119,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Revised,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020119,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Accepted,2021-01-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020119,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Published,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020120,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2020-12-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020120,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2021-01-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020120,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020120,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020121,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)","
Received",2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020121,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020121,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020121,"
(This article belongs to the Special Issue Immune Mechanisms in Plants)", Published,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020122,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)","
Received",2021-01-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020122,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Revised,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020122,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Accepted,2021-02-01
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020122,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Published,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020123,Normal Issue,"
Received",2021-01-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020123,Normal Issue, Revised,2021-01-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020123,Normal Issue, Accepted,2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020123,Normal Issue, Published,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020124,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-11-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020124,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020124,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020124,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020125,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)","
Received",2021-01-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020125,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Revised,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020125,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020125,"
(This article belongs to the Special Issue Research in Immune Responses to Vaccines Antigen during Influenza A Infection)", Published,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020126,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)","
Received",2020-12-24
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020126,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020126,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020126,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Published,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020127,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2020-12-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020127,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020127,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020127,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020128,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)","
Received",2021-01-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020128,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Revised,2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020128,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Accepted,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020128,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Published,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020129,Normal Issue,"
Received",2021-01-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020129,Normal Issue, Revised,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020129,Normal Issue, Accepted,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020129,Normal Issue, Published,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020130,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)","
Received",2021-01-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020130,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Revised,2021-02-01
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020130,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Accepted,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020130,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Published,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020131,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)","
Received",2021-01-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020131,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020131,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Accepted,2021-02-01
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020131,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Published,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020132,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020132,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2021-01-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020132,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020132,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020133,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-12-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020133,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020133,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020133,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020134,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020134,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020134,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020134,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-02-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020135,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)","
Received",2021-01-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020135,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Revised,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020135,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Accepted,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020135,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Published,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020136,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)","
Received",2020-12-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020136,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)", Revised,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020136,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)", Accepted,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020136,"
(This article belongs to the Special Issue Vaccines against Antimicrobial-Resistant Infections)", Published,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020137,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2020-12-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020137,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020137,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020137,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020138,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)","
Received",2020-12-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020138,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Revised,2021-01-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020138,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Accepted,2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020138,"
(This article belongs to the Special Issue Cancer Immunotherapy: Advances and Future Prospects)", Published,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020139,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-01-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020139,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020139,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020139,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020140,"
(This article belongs to the Special Issue Vaccines for Aquaculture)","
Received",2021-01-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020140,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Revised,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020140,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Accepted,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020140,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Published,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020141,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)","
Received",2021-01-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020141,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)", Revised,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020141,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)", Accepted,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020141,"
(This article belongs to the Special Issue Cancer Immunotherapy and Vaccines Research)", Published,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020142,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)","
Received",2020-12-23
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020142,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Revised,2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020142,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Accepted,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020142,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Published,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020143,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2021-01-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020143,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2021-02-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020143,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020143,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020144,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020144,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020144,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020144,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020145,"
(This article belongs to the Special Issue Zika Virus and Immune Response)","
Received",2020-12-01
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020145,"
(This article belongs to the Special Issue Zika Virus and Immune Response)", Revised,2021-01-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020145,"
(This article belongs to the Special Issue Zika Virus and Immune Response)", Accepted,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020145,"
(This article belongs to the Special Issue Zika Virus and Immune Response)", Published,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020146,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2020-12-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020146,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020146,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020146,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020147,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2021-01-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020147,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020147,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020147,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020148,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020148,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Revised,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020148,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020148,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020149,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020149,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Revised,2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020149,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Accepted,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020149,"
(This article belongs to the Special Issue Analysis and Modification of Existing Vaccines for the Development of Next-Generation Vaccines)", Published,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020150,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)","
Received",2021-01-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020150,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Revised,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020150,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Accepted,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020150,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Published,2021-02-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020151,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)","
Received",2021-01-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020151,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Revised,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020151,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020151,"
(This article belongs to the Special Issue Research on Monoclonal Antibodies and Antibody Engineering)", Published,2021-02-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020152,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020152,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020152,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020152,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2021-02-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020153,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020153,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2021-02-06
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020153,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2021-02-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020153,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2021-02-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020154,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)","
Received",2021-01-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020154,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Revised,2021-01-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020154,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020154,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Published,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020155,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-01-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020155,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020155,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020155,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020156,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020156,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020156,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020156,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020157,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2021-01-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020157,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-02-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020157,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-02-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020157,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020158,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)","
Received",2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020158,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Accepted,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020158,"
(This article belongs to the Special Issue Vaccine Development for Herpes Simplex Viruses)", Published,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020159,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)","
Received",2020-12-28
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020159,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Revised,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020159,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Accepted,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020159,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Published,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020160,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2021-01-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020160,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020160,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-02-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020160,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020161,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020161,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020161,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020161,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020162,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020162,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020162,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020162,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020163,"
(This article belongs to the Special Issue Vaccines for Aquaculture)","
Received",2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020163,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Revised,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020163,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Accepted,2021-02-04
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020163,"
(This article belongs to the Special Issue Vaccines for Aquaculture)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020164,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)","
Received",2021-01-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020164,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Revised,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020164,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Accepted,2021-02-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020164,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020165,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)","
Received",2020-11-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020165,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Revised,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020165,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Accepted,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020165,"
(This article belongs to the Special Issue Vaccines and Other Antibody Therapies Against Bacterial Infection)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020166,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-01-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020166,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020166,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020166,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020167,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)","
Received",2021-01-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020167,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Revised,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020167,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Accepted,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020167,"
(This article belongs to the Special Issue Development and Application of New Vaccine against Classical Swine Fever Virus)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020168,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2021-01-26
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020168,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020168,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2021-02-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020168,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020169,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2021-01-25
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020169,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020169,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020169,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020170,"
(This article belongs to the Section Vaccines and Society)","
Received",2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020170,"
(This article belongs to the Section Vaccines and Society)", Revised,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020170,"
(This article belongs to the Section Vaccines and Society)", Accepted,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020170,"
(This article belongs to the Section Vaccines and Society)", Published,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020171,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)","
Received",2020-11-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020171,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Revised,2021-01-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020171,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Accepted,2021-02-09
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020171,"
(This article belongs to the Special Issue B and T Cell-Mediated Immunity)", Published,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020172,"
(This article belongs to the Section Vaccines and Society)","
Received",2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020172,"
(This article belongs to the Section Vaccines and Society)", Revised,2021-02-11
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020172,"
(This article belongs to the Section Vaccines and Society)", Accepted,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020172,"
(This article belongs to the Section Vaccines and Society)", Published,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020173,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)","
Received",2021-02-02
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020173,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Revised,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020173,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Accepted,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020173,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Published,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020174,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020174,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020174,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020174,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-02-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2021-02-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020175,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2021-02-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020176,"
(This article belongs to the Special Issue HIV Vaccine)","
Received",2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020176,"
(This article belongs to the Special Issue HIV Vaccine)", Revised,2021-02-07
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020176,"
(This article belongs to the Special Issue HIV Vaccine)", Accepted,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020176,"
(This article belongs to the Special Issue HIV Vaccine)", Published,2021-02-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020177,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)","
Received",2020-12-31
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020177,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Revised,2021-02-03
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020177,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Accepted,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020177,"
(This article belongs to the Special Issue Vaccines for Ebola Virus and Related Diseases)", Published,2021-02-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020178,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)","
Received",2021-01-29
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020178,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Revised,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020178,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Accepted,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020178,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Published,2021-02-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020179,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2021-01-27
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020179,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020179,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020179,"
(This article belongs to the Section Veterinary Vaccines)", Published,2021-02-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020180,"
(This article belongs to the Special Issue Infectious Diseases Immunology)","
Received",2021-01-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020180,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Revised,2021-02-10
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020180,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Accepted,2021-02-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020180,"
(This article belongs to the Special Issue Infectious Diseases Immunology)", Published,2021-02-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020181,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-01-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020181,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-02-15
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020181,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020181,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-02-20
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020182,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)","
Received",2020-12-08
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020182,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Revised,2021-02-12
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020182,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Accepted,2021-02-14
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020182,"
(This article belongs to the Special Issue Vaccine Research against Significant Viral Diseases of Poultry)", Published,2021-02-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020183,"
(This article belongs to the Special Issue Women's Disease and Related Vaccine)","
Received",2020-12-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020183,"
(This article belongs to the Special Issue Women's Disease and Related Vaccine)", Revised,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020183,"
(This article belongs to the Special Issue Women's Disease and Related Vaccine)", Accepted,2021-02-18
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020183,"
(This article belongs to the Special Issue Women's Disease and Related Vaccine)", Published,2021-02-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020184,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)","
Received",2020-12-21
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020184,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Revised,2021-02-13
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020184,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Accepted,2021-02-16
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020184,"
(This article belongs to the Special Issue Controlled Clinical Evaluation of Veterinary Vaccines)", Published,2021-02-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020185,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)","
Received",2021-01-30
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020185,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Revised,2021-02-17
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020185,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Accepted,2021-02-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020185,"
(This article belongs to the Special Issue PRRSV Vaccinology and Immunology)", Published,2021-02-22
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020186,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-01-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020186,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-02-05
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020186,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-02-19
Vaccines,2021,9,2,https://doi.org/10.3390/vaccines9020186,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030187,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-01-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030187,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030187,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030187,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030188,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2021-01-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030188,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2021-02-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030188,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2021-02-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030188,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030189,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)","
Received",2021-01-29
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030189,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Revised,2021-02-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030189,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Accepted,2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030189,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Published,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030190,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2021-01-21
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030190,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-02-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030190,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-02-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030190,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030191,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)","
Received",2021-01-29
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030191,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Revised,2021-02-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030191,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Accepted,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030191,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Published,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030192,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)","
Received",2021-01-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030192,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Revised,2021-02-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030192,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Accepted,2021-02-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030192,"
(This article belongs to the Special Issue Immune Responses to Influenza Virus Antigens)", Published,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030193,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches 2.0)","
Received",2021-01-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030193,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches 2.0)", Revised,2021-02-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030193,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches 2.0)", Accepted,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030193,"
(This article belongs to the Special Issue New Vaccine Technologies and Approaches 2.0)", Published,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030194,"
(This article belongs to the Section Veterinary Vaccines)","
Received",2020-11-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030194,"
(This article belongs to the Section Veterinary Vaccines)", Revised,2021-01-21
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030194,"
(This article belongs to the Section Veterinary Vaccines)", Accepted,2021-01-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030194,"
(This article belongs to the Section Veterinary Vaccines)", Published,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030195,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)","
Received",2020-12-07
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030195,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Revised,2020-12-30
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030195,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Accepted,2021-01-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030195,"
(This article belongs to the Section Cancer Vaccines and Immunotherapy)", Published,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030196,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030196,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030196,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030196,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030197,"
(This article belongs to the Special Issue HPV-Vaccines)","
Received",2021-01-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030197,"
(This article belongs to the Special Issue HPV-Vaccines)", Revised,2021-02-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030197,"
(This article belongs to the Special Issue HPV-Vaccines)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030197,"
(This article belongs to the Special Issue HPV-Vaccines)", Published,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030198,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)","
Received",2021-01-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030198,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Revised,2021-02-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030198,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Accepted,2021-02-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030198,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Published,2021-02-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030199,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-02-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030199,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030199,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030199,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-02-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030200,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2021-02-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030200,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030200,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030200,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2021-02-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030201,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)","
Received",2021-02-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030201,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Revised,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030201,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030201,"
(This article belongs to the Special Issue Vaccine Hesitancy and Child Immunizations: Rationales, Issues and Knowledge Gaps)", Published,2021-02-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030202,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)","
Received",2021-01-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030202,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Revised,2021-02-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030202,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030202,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Published,2021-02-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030203,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-01-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030203,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030203,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030203,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-02-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030204,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)","
Received",2021-02-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030204,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Revised,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030204,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Accepted,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030204,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Published,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030205,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)","
Received",2021-02-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030205,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Accepted,2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030205,"
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)", Published,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030206,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)","
Received",2021-01-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030206,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Revised,2021-02-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030206,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Accepted,2021-02-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030206,"
(This article belongs to the Special Issue Pharmacoepidemiology in Vaccine: Generating the Real-World Data to Promote Vaccine Safety and Uptake)", Published,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030207,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)","
Received",2021-01-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030207,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Revised,2021-02-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030207,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Accepted,2021-02-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030207,"
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)", Published,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030208,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)","
Received",2021-01-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030208,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030208,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030208,"
(This article belongs to the Special Issue Reverse Vaccinology and Genomics)", Published,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030209,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-01-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030209,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030209,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030209,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030210,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)","
Received",2021-02-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030210,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Revised,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030210,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Accepted,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030210,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030211,"
(This article belongs to the Special Issue Sex Differences in Allergy and Autoimmunity)","
Received",2021-01-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030211,"
(This article belongs to the Special Issue Sex Differences in Allergy and Autoimmunity)", Revised,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030211,"
(This article belongs to the Special Issue Sex Differences in Allergy and Autoimmunity)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030211,"
(This article belongs to the Special Issue Sex Differences in Allergy and Autoimmunity)", Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030212,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2021-02-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030212,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030212,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030212,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030213,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)","
Received",2021-01-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030213,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030213,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030213,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030214,Normal Issue,"
Received",2021-01-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030214,Normal Issue, Revised,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030214,Normal Issue, Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030214,Normal Issue, Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030215,"
(This article belongs to the Special Issue Emerging and Re-emerging Zoonotic Viruses: Current Challenges in Vaccinology)","
Received",2020-12-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030215,"
(This article belongs to the Special Issue Emerging and Re-emerging Zoonotic Viruses: Current Challenges in Vaccinology)", Revised,2021-02-21
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030215,"
(This article belongs to the Special Issue Emerging and Re-emerging Zoonotic Viruses: Current Challenges in Vaccinology)", Accepted,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030215,"
(This article belongs to the Special Issue Emerging and Re-emerging Zoonotic Viruses: Current Challenges in Vaccinology)", Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030216,"
(This article belongs to the Special Issue Poultry Vaccines)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030216,"
(This article belongs to the Special Issue Poultry Vaccines)", Revised,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030216,"
(This article belongs to the Special Issue Poultry Vaccines)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030216,"
(This article belongs to the Special Issue Poultry Vaccines)", Published,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030217,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)","
Received",2021-01-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030217,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Revised,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030217,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Accepted,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030217,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Published,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030218,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)","
Received",2021-02-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030218,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Revised,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030218,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Accepted,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030218,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Published,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030219,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)","
Received",2021-02-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030219,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Revised,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030219,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030219,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Published,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030220,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)","
Received",2021-01-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030220,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030220,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Accepted,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030220,"
(This article belongs to the Special Issue Host Immune Response to Infectious Diseases)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030221,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)","
Received",2021-02-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030221,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Revised,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030221,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030221,"
(This article belongs to the Special Issue When Vaccinations are Challenging: From Immune Diseases to Hypersensitivity Reactions)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030222,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2021-02-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030222,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030222,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030222,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030223,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2021-01-07
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030223,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2021-02-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030223,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030223,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030224,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)","
Received",2021-02-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030224,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030224,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030224,"
(This article belongs to the Special Issue Progress on Seasonal and Pandemic Influenza Vaccines)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030225,"
(This article belongs to the Special Issue Human Host–Microbiota Interactions)","
Received",2021-01-31
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030225,"
(This article belongs to the Special Issue Human Host–Microbiota Interactions)", Revised,2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030225,"
(This article belongs to the Special Issue Human Host–Microbiota Interactions)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030225,"
(This article belongs to the Special Issue Human Host–Microbiota Interactions)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030226,"
(This article belongs to the Section Vaccines and Society)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030226,"
(This article belongs to the Section Vaccines and Society)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030226,"
(This article belongs to the Section Vaccines and Society)", Accepted,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030226,"
(This article belongs to the Section Vaccines and Society)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030227,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)","
Received",2021-02-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030227,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030227,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Accepted,2021-02-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030227,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030228,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)","
Received",2021-02-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030228,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030228,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Accepted,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030228,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Published,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030229,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)","
Received",2021-02-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030229,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030229,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030229,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Published,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030230,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2021-01-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030230,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030230,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030230,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030231,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)","
Received",2021-01-31
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030231,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Revised,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030231,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Accepted,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030231,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Published,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030232,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)","
Received",2021-02-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030232,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Revised,2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030232,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Accepted,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030232,"
(This article belongs to the Special Issue Vaccine Evaluation Methods and Studies)", Published,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030233,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)","
Received",2020-12-31
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030233,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Revised,2021-02-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030233,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Accepted,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030233,"
(This article belongs to the Special Issue Health Technology Assessment (HTA) of New vaccines and New Target Groups and Impact Evaluation and Effectiveness of Current Vaccination Strategies)", Published,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030234,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2021-02-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030234,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030234,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030234,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030235,"
(This article belongs to the Special Issue Tumor Immunotherapy)","
Received",2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030235,"
(This article belongs to the Special Issue Tumor Immunotherapy)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030235,"
(This article belongs to the Special Issue Tumor Immunotherapy)", Accepted,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030235,"
(This article belongs to the Special Issue Tumor Immunotherapy)", Published,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030236,"
(This article belongs to the Special Issue Novel Prophylactic and Therapeutic Strategies against Respiratory Viral Pathogens for Human and Animal Health)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030236,"
(This article belongs to the Special Issue Novel Prophylactic and Therapeutic Strategies against Respiratory Viral Pathogens for Human and Animal Health)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030236,"
(This article belongs to the Special Issue Novel Prophylactic and Therapeutic Strategies against Respiratory Viral Pathogens for Human and Animal Health)", Accepted,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030236,"
(This article belongs to the Special Issue Novel Prophylactic and Therapeutic Strategies against Respiratory Viral Pathogens for Human and Animal Health)", Published,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030237,"
(This article belongs to the Special Issue Advancing Vaccine Research: Contributions from Molecular, Cellular, and Omics Approaches)","
Received",2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030237,"
(This article belongs to the Special Issue Advancing Vaccine Research: Contributions from Molecular, Cellular, and Omics Approaches)", Revised,2021-03-07
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030237,"
(This article belongs to the Special Issue Advancing Vaccine Research: Contributions from Molecular, Cellular, and Omics Approaches)", Accepted,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030237,"
(This article belongs to the Special Issue Advancing Vaccine Research: Contributions from Molecular, Cellular, and Omics Approaches)", Published,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030238,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030238,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030238,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030238,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030239,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2021-02-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030239,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030239,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030239,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030240,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)","
Received",2021-02-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030240,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Revised,2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030240,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Accepted,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030240,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Published,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030241,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)","
Received",2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030241,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Accepted,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030241,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Published,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030242,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)","
Received",2021-01-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030242,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030242,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Accepted,2021-03-07
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030242,"
(This article belongs to the Special Issue African Swine Fever Virus Prevention and Control)", Published,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030243,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030243,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030243,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030243,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030244,"
(This article belongs to the Section Cellular/Molecular Immunology)","
Received",2021-01-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030244,"
(This article belongs to the Section Cellular/Molecular Immunology)", Revised,2021-02-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030244,"
(This article belongs to the Section Cellular/Molecular Immunology)", Accepted,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030244,"
(This article belongs to the Section Cellular/Molecular Immunology)", Published,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030245,"
(This article belongs to the Section Epidemiology)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030245,"
(This article belongs to the Section Epidemiology)", Revised,2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030245,"
(This article belongs to the Section Epidemiology)", Accepted,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030245,"
(This article belongs to the Section Epidemiology)", Published,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030246,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)","
Received",2021-02-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030246,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Revised,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030246,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Accepted,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030246,"
(This article belongs to the Special Issue Vaccines: Uptake and Equity in Times of the COVID-19 Pandemic)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030247,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)","
Received",2021-02-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030247,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Revised,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030247,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Accepted,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030247,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030248,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)","
Received",2021-02-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030248,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Revised,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030248,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Accepted,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030248,"
(This article belongs to the Special Issue Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030249,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030249,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Revised,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030249,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Accepted,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030249,"
(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030250,"
(This article belongs to the Special Issue Health Economics of Vaccines)","
Received",2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030250,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030250,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Accepted,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030250,"
(This article belongs to the Special Issue Health Economics of Vaccines)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030251,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030251,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Revised,2021-03-07
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030251,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Accepted,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030251,"
(This article belongs to the Special Issue Development of Vaccines Based on Virus-Like Particles)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030252,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)","
Received",2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030252,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Revised,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030252,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Accepted,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030252,"
(This article belongs to the Special Issue Foot and Mouth Disease Virus and Novel Vaccines Developments)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030253,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)","
Received",2021-01-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030253,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Revised,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030253,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Accepted,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030253,"
(This article belongs to the Special Issue Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies)", Published,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030254,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030254,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Revised,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030254,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030254,"
(This article belongs to the Special Issue Our Immune System Is the First Line of Defense towards Infections: Modulation of the Immune System to Boost the Host Defense Response towards Pathogens)", Published,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030255,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2021-01-31
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030255,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030255,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030255,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030256,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)","
Received",2021-02-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030256,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030256,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Accepted,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030256,"
(This article belongs to the Special Issue Strategies to Increase Vaccination Coverage and Vaccine Confidence)", Published,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030257,"
(This article belongs to the Special Issue Influenza Virus Vaccine)","
Received",2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030257,"
(This article belongs to the Special Issue Influenza Virus Vaccine)", Revised,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030257,"
(This article belongs to the Special Issue Influenza Virus Vaccine)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030257,"
(This article belongs to the Special Issue Influenza Virus Vaccine)", Published,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030258,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)","
Received",2021-02-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030258,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Revised,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030258,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Accepted,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030258,"
(This article belongs to the Section Attenuated/Inactivated/Live and Vectored Vaccines)", Published,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030259,"
(This article belongs to the Special Issue Bovine Viral Diarrhea/Mucosal Disease)","
Received",2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030259,"
(This article belongs to the Special Issue Bovine Viral Diarrhea/Mucosal Disease)", Revised,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030259,"
(This article belongs to the Special Issue Bovine Viral Diarrhea/Mucosal Disease)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030259,"
(This article belongs to the Special Issue Bovine Viral Diarrhea/Mucosal Disease)", Published,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030260,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)","
Received",2021-02-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030260,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Revised,2021-03-05
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030260,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Accepted,2021-03-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030260,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Published,2021-03-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030261,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-02-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030261,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030261,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030261,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030262,"
(This article belongs to the Special Issue Vectored Vaccines)","
Received",2021-02-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030262,"
(This article belongs to the Special Issue Vectored Vaccines)", Revised,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030262,"
(This article belongs to the Special Issue Vectored Vaccines)", Accepted,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030262,"
(This article belongs to the Special Issue Vectored Vaccines)", Published,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030263,"
(This article belongs to the Special Issue Study on the Prevention and Treatment of Arbovirus)","
Received",2021-02-08
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030263,"
(This article belongs to the Special Issue Study on the Prevention and Treatment of Arbovirus)", Revised,2021-03-07
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030263,"
(This article belongs to the Special Issue Study on the Prevention and Treatment of Arbovirus)", Accepted,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030263,"
(This article belongs to the Special Issue Study on the Prevention and Treatment of Arbovirus)", Published,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030264,Normal Issue,"
Received",2021-02-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030264,Normal Issue, Revised,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030264,Normal Issue, Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030264,Normal Issue, Published,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030265,"
(This article belongs to the Special Issue Pneumococcal Conjugate Vaccines and Prevention of Non-invasive and Invasive Pneumococcal Diseases)","
Received",2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030265,"
(This article belongs to the Special Issue Pneumococcal Conjugate Vaccines and Prevention of Non-invasive and Invasive Pneumococcal Diseases)", Revised,2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030265,"
(This article belongs to the Special Issue Pneumococcal Conjugate Vaccines and Prevention of Non-invasive and Invasive Pneumococcal Diseases)", Accepted,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030265,"
(This article belongs to the Special Issue Pneumococcal Conjugate Vaccines and Prevention of Non-invasive and Invasive Pneumococcal Diseases)", Published,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030266,Normal Issue,"
Received",2021-01-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030266,Normal Issue, Revised,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030266,Normal Issue, Accepted,2021-03-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030266,Normal Issue, Published,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030267,Normal Issue,"
Received",2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030267,Normal Issue, Revised,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030267,Normal Issue, Accepted,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030267,Normal Issue, Published,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030268,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)","
Received",2021-02-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030268,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Revised,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030268,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Accepted,2021-03-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030268,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Published,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030269,"
(This article belongs to the Special Issue Present and Future Vaccinations: Current Strategies and New Perspectives in the Fight against Infectious Diseases)","
Received",2021-02-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030269,"
(This article belongs to the Special Issue Present and Future Vaccinations: Current Strategies and New Perspectives in the Fight against Infectious Diseases)", Revised,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030269,"
(This article belongs to the Special Issue Present and Future Vaccinations: Current Strategies and New Perspectives in the Fight against Infectious Diseases)", Accepted,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030269,"
(This article belongs to the Special Issue Present and Future Vaccinations: Current Strategies and New Perspectives in the Fight against Infectious Diseases)", Published,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030270,"
(This article belongs to the Special Issue Vaccines for Leishmaniasis and the Implications of Their Development)","
Received",2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030270,"
(This article belongs to the Special Issue Vaccines for Leishmaniasis and the Implications of Their Development)", Revised,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030270,"
(This article belongs to the Special Issue Vaccines for Leishmaniasis and the Implications of Their Development)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030270,"
(This article belongs to the Special Issue Vaccines for Leishmaniasis and the Implications of Their Development)", Published,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030271,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)","
Received",2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030271,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030271,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030271,"
(This article belongs to the Special Issue Mucosal Responses in the Context of Natural Immunity to HIV)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030272,"
(This article belongs to the Special Issue Research on Malaria Immunology in Animal Models)","
Received",2021-02-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030272,"
(This article belongs to the Special Issue Research on Malaria Immunology in Animal Models)", Revised,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030272,"
(This article belongs to the Special Issue Research on Malaria Immunology in Animal Models)", Accepted,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030272,"
(This article belongs to the Special Issue Research on Malaria Immunology in Animal Models)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030273,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)","
Received",2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030273,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030273,"
(This article belongs to the Special Issue Virus-Like Particle & Nanoparticle Vaccines against Viral Infections)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030274,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)","
Received",2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030274,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Revised,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030274,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030274,"
(This article belongs to the Special Issue Advances in COVID-19 Vaccines Development)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030275,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)","
Received",2021-01-21
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030275,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Revised,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030275,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030275,"
(This article belongs to the Special Issue Vaccination and Public Health: Optimizing Vaccine Uptake through the Application of Social and Behavioral Science Theory, Principles, and Strategies)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030276,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2021-01-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030276,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030276,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030276,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030277,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)","
Received",2021-02-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030277,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030277,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030277,"
(This article belongs to the Special Issue Adjuvants and Antigen Delivery Systems for Tuberculosis Subunit Vaccines)", Published,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030278,Normal Issue,"
Received",2021-01-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030278,Normal Issue, Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030278,Normal Issue, Accepted,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030278,Normal Issue, Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030279,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)","
Received",2021-01-29
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030279,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Revised,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030279,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030279,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030280,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2021-01-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030280,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030280,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030280,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030281,Normal Issue,"
Received",2021-02-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030281,Normal Issue, Revised,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030281,Normal Issue, Accepted,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030281,Normal Issue, Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030282,"
(This article belongs to the Special Issue Epidemiology of COVID-19)","
Received",2021-02-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030282,"
(This article belongs to the Special Issue Epidemiology of COVID-19)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030282,"
(This article belongs to the Special Issue Epidemiology of COVID-19)", Accepted,2021-03-10
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030282,"
(This article belongs to the Special Issue Epidemiology of COVID-19)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030283,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)","
Received",2021-02-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030283,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030283,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Accepted,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030283,"
(This article belongs to the Special Issue Research, Advances, Challenges and Perspectives in the Development of Vaccines against Dengue, Zika and Chikungunya Viruses)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030284,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)","
Received",2021-02-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030284,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)", Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030284,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)", Accepted,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030284,"
(This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030285,"
(This article belongs to the Special Issue The Path towards Effective Vaccines for Chronic Viral Infections)","
Received",2021-01-31
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030285,"
(This article belongs to the Special Issue The Path towards Effective Vaccines for Chronic Viral Infections)", Revised,2021-02-26
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030285,"
(This article belongs to the Special Issue The Path towards Effective Vaccines for Chronic Viral Infections)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030285,"
(This article belongs to the Special Issue The Path towards Effective Vaccines for Chronic Viral Infections)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030286,"
(This article belongs to the Section Influenza Virus Vaccines)","
Received",2021-01-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030286,"
(This article belongs to the Section Influenza Virus Vaccines)", Revised,2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030286,"
(This article belongs to the Section Influenza Virus Vaccines)", Accepted,2021-03-11
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030286,"
(This article belongs to the Section Influenza Virus Vaccines)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030287,"
(This article belongs to the Special Issue Epidemiology of COVID-19)","
Received",2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030287,"
(This article belongs to the Special Issue Epidemiology of COVID-19)", Revised,2021-03-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030287,"
(This article belongs to the Special Issue Epidemiology of COVID-19)", Accepted,2021-03-14
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030287,"
(This article belongs to the Special Issue Epidemiology of COVID-19)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030288,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)","
Received",2021-01-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030288,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030288,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Accepted,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030288,"
(This article belongs to the Special Issue Herpesvirus-Specific Immunomonitoring in Patient Groups of Increased Risk)", Published,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030289,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)","
Received",2021-02-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030289,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Revised,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030289,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Accepted,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030289,"
(This article belongs to the Special Issue Evaluation of Vaccine Immunogenicity)", Published,2021-03-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030290,Normal Issue,"
Received",2021-02-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030290,Normal Issue, Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030290,Normal Issue, Accepted,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030290,Normal Issue, Published,2021-03-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030291,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)","
Received",2021-02-24
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030291,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030291,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Accepted,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030291,"
(This article belongs to the Special Issue Feature Papers of “Advances in Vaccine Development”)", Published,2021-03-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030292,"
(This article belongs to the Special Issue Vaccination Strategies for COVID-19)","
Received",2021-02-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030292,"
(This article belongs to the Special Issue Vaccination Strategies for COVID-19)", Revised,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030292,"
(This article belongs to the Special Issue Vaccination Strategies for COVID-19)", Accepted,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030292,"
(This article belongs to the Special Issue Vaccination Strategies for COVID-19)", Published,2021-03-21
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030293,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)","
Received",2021-03-03
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030293,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Revised,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030293,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Accepted,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030293,"
(This article belongs to the Special Issue Vaccines against Hepatitis Viruses)", Published,2021-03-21
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030294,"
(This article belongs to the Special Issue Zika Virus and Immune Response)","
Received",2021-02-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030294,"
(This article belongs to the Special Issue Zika Virus and Immune Response)", Revised,2021-03-12
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030294,"
(This article belongs to the Special Issue Zika Virus and Immune Response)", Accepted,2021-03-13
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030294,"
(This article belongs to the Special Issue Zika Virus and Immune Response)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030295,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)","
Received",2021-01-28
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030295,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Revised,2021-03-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030295,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Accepted,2021-03-09
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030295,"
(This article belongs to the Special Issue Measles-Mumps-Rubella-Varicella Vaccination)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030296,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)","
Received",2021-03-01
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030296,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Revised,2021-03-15
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030296,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Accepted,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030296,"
(This article belongs to the Special Issue Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030297,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)","
Received",2021-03-06
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030297,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Revised,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030297,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Accepted,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030297,"
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030298,"
(This article belongs to the Section Vaccines and Society)","
Received",2021-02-25
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030298,"
(This article belongs to the Section Vaccines and Society)", Revised,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030298,"
(This article belongs to the Section Vaccines and Society)", Accepted,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030298,"
(This article belongs to the Section Vaccines and Society)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030299,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)","
Received",2021-01-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030299,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Revised,2021-02-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030299,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Accepted,2021-02-27
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030299,"
(This article belongs to the Special Issue Vaccines for Infectious and Chronic Diseases)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030300,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)","
Received",2021-02-04
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030300,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Revised,2021-03-16
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030300,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Accepted,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030300,"
(This article belongs to the Section COVID-19 Vaccines and Vaccination)", Published,2021-03-22
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030301,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2021-02-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030301,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2021-03-18
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030301,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2021-03-20
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030301,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2021-03-23
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030303,"
(This article belongs to the Section Clinical Immunology)","
Received",2021-03-02
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030303,"
(This article belongs to the Section Clinical Immunology)", Revised,2021-03-17
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030303,"
(This article belongs to the Section Clinical Immunology)", Accepted,2021-03-19
Vaccines,2021,9,3,https://doi.org/10.3390/vaccines9030303,"
(This article belongs to the Section Clinical Immunology)", Published,2021-03-23
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040305,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)","
Received",2021-03-08
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040305,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Revised,2021-03-19
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040305,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Accepted,2021-03-22
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040305,"
(This article belongs to the Special Issue Recent Advances in Novel Pneumococcal Vaccines)", Published,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040306,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)","
Received",2021-02-12
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040306,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Revised,2021-03-14
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040306,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Accepted,2021-03-17
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040306,"
(This article belongs to the Special Issue Immune Ontogeny and Vaccination in Early Life)", Published,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040307,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)","
Received",2021-02-10
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040307,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Revised,2021-03-18
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040307,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Accepted,2021-03-20
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040307,"
(This article belongs to the Collection COVID-19 Vaccines and Vaccination)", Published,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040308,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2021-02-16
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040308,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2021-03-19
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040308,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2021-03-19
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040308,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040309,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2021-01-27
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040309,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2021-03-05
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040309,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2021-03-17
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040309,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040310,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)","
Received",2021-02-15
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040310,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Revised,2021-03-18
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040310,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Accepted,2021-03-23
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040310,"
(This article belongs to the Special Issue Vaccine Formulation for Infectious Diseases and Adjuvant Mechanisms of Action)", Published,2021-03-25
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040311,"
(This article belongs to the Special Issue Next-Generation HIV Antiretroviral Therapy and Vaccine Candidates)","
Received",2021-02-16
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040311,"
(This article belongs to the Special Issue Next-Generation HIV Antiretroviral Therapy and Vaccine Candidates)", Revised,2021-03-15
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040311,"
(This article belongs to the Special Issue Next-Generation HIV Antiretroviral Therapy and Vaccine Candidates)", Accepted,2021-03-23
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040311,"
(This article belongs to the Special Issue Next-Generation HIV Antiretroviral Therapy and Vaccine Candidates)", Published,2021-03-25
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040312,"
(This article belongs to the Section Vaccines and Society)","
Received",2021-03-02
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040312,"
(This article belongs to the Section Vaccines and Society)", Revised,2021-03-18
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040312,"
(This article belongs to the Section Vaccines and Society)", Accepted,2021-03-20
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040312,"
(This article belongs to the Section Vaccines and Society)", Published,2021-03-26
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040313,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)","
Received",2021-02-21
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040313,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Revised,2021-03-11
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040313,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Accepted,2021-03-16
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040313,"
(This article belongs to the Section Vaccines against (re)emerging and Tropical Infections Diseases)", Published,2021-03-26
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040314,"
(This article belongs to the Section Vaccines and Society)","
Received",2021-02-04
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040314,"
(This article belongs to the Section Vaccines and Society)", Revised,2021-03-16
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040314,"
(This article belongs to the Section Vaccines and Society)", Accepted,2021-03-19
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040314,"
(This article belongs to the Section Vaccines and Society)", Published,2021-03-29
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040315,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)","
Received",2021-03-03
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040315,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Revised,2021-03-22
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040315,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Accepted,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040315,"
(This article belongs to the Special Issue Human Consciousness and Behavior towards Infectious Diseases and Vaccines)", Published,2021-03-29
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040316,"
(This article belongs to the Section Vaccines against Infectious Diseases)","
Received",2021-02-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040316,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Revised,2021-03-23
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040316,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Accepted,2021-03-24
Vaccines,2021,9,4,https://doi.org/10.3390/vaccines9040316,"
(This article belongs to the Section Vaccines against Infectious Diseases)", Published,2021-03-29
